Inhibition	O
of	O
CD28/CD3-mediated	O
costimulation	O
of	O
naive	B-cell_type
and	I-cell_type
memory	I-cell_type
human	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
by	O
intracellular	O
incorporation	O
of	O
polyclonal	B-protein
antibodies	I-protein
specific	O
for	O
the	O
activator	B-protein
protein-1	I-protein
transcriptional	I-protein
complex	I-protein
.	O

A	O
number	O
of	O
indirect	O
methods	O
have	O
been	O
utilized	O
in	O
demonstrating	O
activator	B-protein
protein-1	I-protein
transcription	O
factor	O
function	O
in	O
IL-2	O
promoter	O
activity	O
.	O

However	O
,	O
there	O
has	O
been	O
no	O
direct	O
demonstration	O
that	O
activator	B-protein
protein-1	I-protein
is	O
involved	O
in	O
CD28-dependent	O
costimulation	O
of	O
IL-2	B-DNA
gene	I-DNA
transcription	O
in	O
freshly	O
isolated	O
naive	B-cell_type
and	I-cell_type
memory	I-cell_type
human	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
.	O

To	O
address	O
this	O
issue	O
,	O
the	O
method	O
of	O
scrape	O
loading	O
was	O
applied	O
to	O
purified	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
.	O

Since	O
scrape	O
loading	O
relies	O
on	O
adherent	B-cell_type
cells	I-cell_type
,	O
peripheral	B-cell_type
blood	I-cell_type
human	I-cell_type
T	I-cell_type
(	I-cell_type
PB-T	I-cell_type
)	I-cell_type
cells	I-cell_type
were	O
immobilized	O
on	O
the	O
nonspecific	O
cell	O
attachment	O
factor	O
poly-L-lysine	O
.	O

Cells	O
scraped	O
off	O
poly-L-lysine	O
in	O
the	O
presence	O
of	O
Ig	B-protein
FITC	I-protein
efficiently	O
incorporated	O
Ig	O
,	O
with	O
relatively	O
uniform	O
fluorescence	O
.	O

T	O
cells	O
retained	O
their	O
physical	O
parameters	O
as	O
measured	O
by	O
forward	O
and	O
side	O
light	O
scatter	O
,	O
and	O
functional	O
activity	O
as	O
measured	O
by	O
costimulation	O
of	O
proliferation	O
and	O
IL-2	B-protein
production	O
after	O
being	O
scraped	O
off	O
this	O
substrate	O
.	O

CD28/CD3-costimulated	B-cell_type
T	I-cell_type
cells	I-cell_type
produced	O
intracellular	O
IL-2	B-protein
from	O
all	O
subsets	O
measured	O
(	O
CD4+	B-cell_type
,	O
CD4-	B-cell_type
,	O
CD45RO+	B-cell_type
,	O
and	O
CD45RO-	B-cell_type
)	O
.	O

IL-2	B-protein
production	O
and	O
intracellular	O
accumulation	O
in	O
nonscraped	O
PB-T	B-cell_type
cells	I-cell_type
activated	O
with	O
CD28/CD3	O
coligation	O
were	O
skewed	O
favoring	O
CD45RO+	B-cell_type
and	I-cell_type
CD4+	I-cell_type
subsets	I-cell_type
,	O
as	O
was	O
IL-2	B-protein
production	O
in	O
scraped	O
PB-T	B-cell_type
cells	I-cell_type
.	O

The	O
intracellular	O
incorporation	O
of	O
Abs	O
specific	O
for	O
c-Fos	B-protein
and	I-protein
c-Jun	I-protein
family	I-protein
members	I-protein
by	O
scrape	O
loading	O
inhibited	O
the	O
production	O
and	O
intracellular	O
accumulation	O
of	O
IL-2	B-protein
within	O
6	O
h	O
of	O
costimulation	O
with	O
PMA/ionomycin	O
,	O
or	O
costimulation	O
by	O
CD28	O
and	O
CD3	O
ligation	O
.	O

Scrape	O
loading	O
thus	O
provides	O
an	O
efficient	O
mechanism	O
for	O
intracellular	O
incorporation	O
of	O
macromolecules	O
,	O
and	O
the	O
first	O
direct	O
evidence	O
that	O
c-Fos	B-protein
and	O
c-Jun	B-protein
are	O
involved	O
in	O
transcription	O
of	O
the	O
IL-2	B-DNA
gene	I-DNA
within	O
its	O
correct	O
chromosomal	O
context	O
,	O
in	O
resting	O
human	O
T	O
lymphocyte	O
subpopulations	O
.	O

x	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
BioLegend®	NULL
#	NULL
m	NULL
meJournal	NULL
of	NULL
Inhibition	NULL
of	NULL
CD28/CD3-Mediated	NULL
Costimulation	NULL
'D	NULL
Immunol	NULL
of	NULL
Naive	NULL
and	NULL
Memory	NULL
Human	NULL
T	NULL
Lymphocytes	NULL
by	NULL
unoiogy	NULL
Intracellular	NULL
Incorporation	NULL
of	NULL
Polyclonal	NULL
Antibodies	NULL
Specific	NULL
for	NULL
the	NULL
Activator	NULL
Protein-1	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
Transcriptional	NULL
Complex	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Darren	NULL
G.	NULL
Woodside	NULL
and	NULL
Bradley	NULL
W.	NULL
McIntyre	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:649-658	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/2/649	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
39	NULL
articles	NULL
,	NULL
26	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.jimmunol.org/content/161/2/649	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
Inhibition	NULL
of	NULL
CD28/CD3-Mediated	NULL
Costimulation	NULL
of	NULL
Naive	NULL
and	NULL
Memory	NULL
Human	NULL
T	NULL
Lymphocytes	NULL
by	NULL
Intracellular	NULL
Incorporation	NULL
of	NULL
Polyclonal	NULL
Antibodies	NULL
Specific	NULL
for	NULL
the	NULL
Activator	NULL
Protein-1	NULL
Transcriptional	NULL
Complex	NULL
'	NULL
Darren	NULL
G.	NULL
Woodside	NULL
and	NULL
Bradley	NULL
W.	NULL
McIntyre	NULL
A	NULL
number	NULL
of	NULL
indirect	NULL
methods	NULL
have	NULL
been	NULL
utilized	NULL
in	NULL
demonstrating	NULL
activator	NULL
protein-1	NULL
transcription	NULL
factor	NULL
function	NULL
in	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
there	NULL
has	NULL
been	NULL
no	NULL
direct	NULL
demonstration	NULL
that	NULL
activator	NULL
protein-1	NULL
is	NULL
involved	NULL
in	NULL
CD28-dependent	NULL
costimulation	NULL
of	NULL
IL-2	NULL
gene	NULL
transcription	NULL
in	NULL
freshly	NULL
isolated	NULL
naive	NULL
and	NULL
memory	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

To	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
the	NULL
method	NULL
of	NULL
scrape	NULL
loading	NULL
was	NULL
applied	NULL
to	NULL
purified	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
.	NULL

Since	NULL
scrape	NULL
loading	NULL
relies	NULL
on	NULL
adherent	NULL
cells	NULL
,	NULL
peripheral	NULL
blood	NULL
human	NULL
T	NULL
(	NULL
PB-T	NULL
)	NULL
cells	NULL
were	NULL
immobilized	NULL
on	NULL
the	NULL
nonspecific	NULL
cell	NULL
attachment	NULL
factor	NULL
poly-L-lysine	NULL
.	NULL

Cells	NULL
scraped	NULL
off	NULL
poly-L-lysine	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Ig	NULL
FITC	NULL
efficiently	NULL
incorporated	NULL
Ig	NULL
,	NULL
with	NULL
relatively	NULL
uniform	NULL
fluorescence	NULL
.	NULL

T	NULL
cells	NULL
retained	NULL
their	NULL
physical	NULL
parameters	NULL
as	NULL
measured	NULL
by	NULL
forward	NULL
and	NULL
side	NULL
light	NULL
scatter	NULL
,	NULL
and	NULL
functional	NULL
activity	NULL
as	NULL
measured	NULL
by	NULL
costimulation	NULL
of	NULL
proliferation	NULL
and	NULL
IL-2	NULL
production	NULL
after	NULL
being	NULL
scraped	NULL
off	NULL
this	NULL
substrate	NULL
.	NULL

CD28/CD3-costimulated	NULL
T	NULL
cells	NULL
produced	NULL
intracellular	NULL
IL-2	NULL
from	NULL
all	NULL
subsets	NULL
measured	NULL
(	NULL
CD4*	NULL
,	NULL
CD4~	NULL
,	NULL
CD45RO*	NULL
,	NULL
and	NULL
CD45RO~	NULL
)	NULL
.	NULL

IL-2	NULL
production	NULL
and	NULL
intracellular	NULL
accumulation	NULL
in	NULL
nonscraped	NULL
PB-T	NULL
cells	NULL
activated	NULL
with	NULL
CD28/CD3	NULL
coligation	NULL
were	NULL
skewed	NULL
favoring	NULL
CD45RO*	NULL
and	NULL
CD4*	NULL
subsets	NULL
,	NULL
as	NULL
was	NULL
IL-2	NULL
production	NULL
in	NULL
scraped	NULL
PB-T	NULL
cells	NULL
.	NULL

The	NULL
intracellular	NULL
incorporation	NULL
of	NULL
Abs	NULL
specific	NULL
for	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
family	NULL
members	NULL
by	NULL
scrape	NULL
loading	NULL
inhibited	NULL
the	NULL
production	NULL
and	NULL
intracellular	NULL
accumulation	NULL
of	NULL
IL-2	NULL
within	NULL
6	NULL
h	NULL
of	NULL
costimulation	NULL
with	NULL
PMA/ionomycin	NULL
,	NULL
or	NULL
costimulation	NULL
by	NULL
CD28	NULL
and	NULL
CD3	NULL
ligation	NULL
.	NULL

Scrape	NULL
loading	NULL
thus	NULL
provides	NULL
an	NULL
efficient	NULL
mechanism	NULL
for	NULL
intracellular	NULL
incorporation	NULL
of	NULL
macromolecules	NULL
,	NULL
and	NULL
the	NULL
first	NULL
direct	NULL
evidence	NULL
that	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
are	NULL
involved	NULL
in	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
within	NULL
its	NULL
correct	NULL
chromosomal	NULL
context	NULL
,	NULL
in	NULL
resting	NULL
human	NULL
T	NULL
lymphocyte	NULL
subpopulations	NULL
.	NULL

-	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
:	NULL
649-658.	NULL
tween	NULL
the	NULL
signals	NULL
generated	NULL
through	NULL
TCR/MHC	NULL
interac-	NULL
tions	NULL
and	NULL
signals	NULL
provided	NULL
by	NULL
costimulatory	NULL
molecules	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
provides	NULL
a	NULL
mechanism	NULL
whereby	NULL
T	NULL
cell	NULL
clonal	NULL
expansion	NULL
can	NULL
take	NULL
place	NULL
in	NULL
the	NULL
correct	NULL
antigenic	NULL
context	NULL
,	NULL
effectively	NULL
lowering	NULL
TCR-signaling	NULL
thresholds	NULL
required	NULL
for	NULL
specific	NULL
immune	NULL
responses	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
interdependency	NULL
of	NULL
both	NULL
of	NULL
these	NULL
signals	NULL
for	NULL
functional	NULL
T	NULL
lymphocyte	NULL
coactivation	NULL
is	NULL
emphasized	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
triggering	NULL
the	NULL
TCR	NULL
alone	NULL
results	NULL
in	NULL
a	NULL
state	NULL
of	NULL
Ag	NULL
unresponsiveness	NULL
(	NULL
3	NULL
)	NULL
.	NULL

IL-2	NULL
is	NULL
a	NULL
key	NULL
player	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
anergic	NULL
states	NULL
,	NULL
and	NULL
costimulation	NULL
through	NULL
the	NULL
CD28	NULL
cell	NULL
surface	NULL
molecule	NULL
dramatically	NULL
induces	NULL
its	NULL
expression	NULL
(	NULL
4	NULL
)	NULL
.	NULL

There	NULL
are	NULL
two	NULL
mechanisms	NULL
controlling	NULL
IL-2	NULL
expression	NULL
initiated	NULL
by	NULL
CD28	NULL
costimulation	NULL
.	NULL

One	NULL
mechanism	NULL
involves	NULL
stabilization	NULL
of	NULL
IL-2	NULL
message	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
other	NULL
,	NULL
and	NULL
perhaps	NULL
the	NULL
main	NULL
mechanism	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
seems	NULL
to	NULL
be	NULL
regulation	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Indirect	NULL
evidence	NULL
demonstrating	NULL
transcription	NULL
factor	NULL
involvement	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
has	NULL
been	NULL
provided	NULL
mainly	NULL
by	NULL
a	NULL
number	NULL
of	NULL
molecular	NULL
approaches	NULL
.	NULL

These	NULL
include	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
DNA	NULL
footprinting	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
(	NULL
9	NULL
)	NULL
and	NULL
supershift	NULL
T	NULL
lymphocyte	NULL
activation	NULL
requires	NULL
complex	NULL
synergism	NULL
be	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
M.	NULL
D.	NULL
Anderson	NULL
Cancer	NULL
Center	NULL
,	NULL
Houston	NULL
,	NULL
TX	NULL
77030	NULL
Received	NULL
for	NULL
publication	NULL
June	NULL
5	NULL
,	NULL
1997	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
March	NULL
17	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
CA62596	NULL
and	NULL
Kleberg	NULL
Foundation	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Brad	NULL
Mcintyre	NULL
,	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
M.	NULL
D.	NULL
Anderson	NULL
Cancer	NULL
Center	NULL
,	NULL
1515	NULL
Holcombe	NULL
Blvd	NULL
.	NULL

,	NULL
Box	NULL
180	NULL
,	NULL
Houston	NULL
,	NULL
TX	NULL
77030	NULL
.	NULL

Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
assays	NULL
(	NULL
10	NULL
)	NULL
of	NULL
nuclear	NULL
protein	NULL
extracts	NULL
,	NULL
and	NULL
transcriptional	NULL
reporter	NULL
assays	NULL
involving	NULL
extrachromosomal	NULL
promoters	NULL
transfected	NULL
into	NULL
T	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
current	NULL
view	NULL
is	NULL
that	NULL
IL-2	NULL
transcription	NULL
involves	NULL
the	NULL
coordinate	NULL
regulation	NULL
of	NULL
disparate	NULL
transcription	NULL
factors	NULL
,	NULL
in	NULL
which	NULL
maximal	NULL
promoter	NULL
activity	NULL
relies	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
all	NULL
factors	NULL
(	NULL
8	NULL
)	NULL
.	NULL

One	NULL
of	NULL
the	NULL
major	NULL
components	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
the	NULL
activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
°	NULL
(	NULL
7	NULL
)	NULL
.	NULL

This	NULL
transcriptional	NULL
complex	NULL
is	NULL
composed	NULL
of	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
proto-oncogene	NULL
families	NULL
arranged	NULL
in	NULL
hetero-	NULL
and	NULL
homodimers	NULL
,	NULL
and	NULL
can	NULL
associate	NULL
with	NULL
different	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
octamer-binding	NULL
protein	NULL
(	NULL
Oct	NULL
)	NULL
and	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

This	NULL
allows	NULL
the	NULL
possibility	NULL
of	NULL
five	NULL
different	NULL
interaction	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
besides	NULL
its	NULL
own	NULL
consensus	NULL
binding	NULL
site	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
this	NULL
,	NULL
AP-1	NULL
is	NULL
thought	NULL
of	NULL
as	NULL
a	NULL
key	NULL
regulator	NULL
in	NULL
IL-2	NULL
gene	NULL
expression	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
AP-1	NULL
activity	NULL
is	NULL
proposed	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
c-rel	NULL
,	NULL
which	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
implicated	NULL
in	NULL
IL-2	NULL
promoter	NULL
activity	NULL
(	NULL
13	NULL
)	NULL
.	NULL

There	NULL
has	NULL
been	NULL
,	NULL
however	NULL
,	NULL
no	NULL
direct	NULL
demonstration	NULL
that	NULL
AP-1	NULL
is	NULL
necessary	NULL
in	NULL
the	NULL
costimulation	NULL
of	NULL
IL-2	NULL
production	NULL
in	NULL
freshly	NULL
isolated	NULL
human	NULL
naive	NULL
or	NULL
memory	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
.	NULL

Genetic	NULL
approaches	NULL
have	NULL
not	NULL
provided	NULL
conclusive	NULL
results	NULL
.	NULL

Whole	NULL
populations	NULL
of	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
mice	NULL
deficient	NULL
in	NULL
c-Fos	NULL
or	NULL
c-Jun	NULL
genes	NULL
have	NULL
no	NULL
noticeable	NULL
differences	NULL
in	NULL
development	NULL
,	NULL
cytokine	NULL
induction	NULL
,	NULL
or	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
stimulation	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
molecular	NULL
genetic	NULL
approaches	NULL
have	NULL
not	NULL
demonstrated	NULL
the	NULL
role	NULL
played	NULL
by	NULL
these	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
control	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
AP-1	NULL
,	NULL
activator	NULL
protein-1	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
FN	NULL
,	NULL
fibronectin	NULL
;	NULL
GAR	NULL
,	NULL
goat	NULL
anti-rabbit	NULL
;	NULL
MFI	NULL
,	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
;	NULL
NF-AT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
;	NULL
PB-T	NULL
,	NULL
peripheral	NULL
blood	NULL
human	NULL
T	NULL
;	NULL
PE	NULL
,	NULL
phycoerythrin	NULL
;	NULL
RAM	NULL
,	NULL
rabbit	NULL
anti-mouse	NULL
.	NULL

0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
650	NULL
CD28/CD3	NULL
COSTIMULATION	NULL
OF	NULL
PRIMARY	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
REQUIRES	NULL
AP-1	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

Nor	NULL
have	NULL
basic	NULL
molecular	NULL
approaches	NULL
addressed	NULL
the	NULL
question	NULL
of	NULL
function	NULL
or	NULL
necessity	NULL
of	NULL
the	NULL
identified	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
costimulation	NULL
of	NULL
IL-2	NULL
production	NULL
in	NULL
resting	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
in	NULL
an	NULL
in	NULL
vivo	NULL
,	NULL
intact	NULL
cell	NULL
model	NULL
,	NULL
in	NULL
which	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
in	NULL
its	NULL
correct	NULL
original	NULL
chromosomal	NULL
context	NULL
.	NULL

To	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
we	NULL
have	NULL
developed	NULL
a	NULL
method	NULL
independent	NULL
of	NULL
genetic	NULL
manipulation	NULL
for	NULL
determining	NULL
transcription	NULL
factor	NULL
activity	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
(	NULL
PB-T	NULL
)	NULL
lymphocytes	NULL
.	NULL

This	NULL
method	NULL
involves	NULL
scrape	NULL
loading	NULL
Abs	NULL
specific	NULL
for	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
into	NULL
freshly	NULL
isolated	NULL
T	NULL
lymphocytes	NULL
.	NULL

By	NULL
this	NULL
method	NULL
,	NULL
T	NULL
lymphocytes	NULL
adherent	NULL
to	NULL
plastic	NULL
coated	NULL
with	NULL
the	NULL
nonspecific	NULL
cell	NULL
attachment	NULL
factor	NULL
poly-L-lysine	NULL
are	NULL
physically	NULL
scraped	NULL
off	NULL
the	NULL
plastic	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
transient	NULL
perforation	NULL
or	NULL
tear	NULL
in	NULL
the	NULL
cell	NULL
surface	NULL
membrane	NULL
.	NULL

Since	NULL
the	NULL
medium	NULL
in	NULL
which	NULL
the	NULL
scrape	NULL
loading	NULL
occurs	NULL
has	NULL
been	NULL
spiked	NULL
with	NULL
anti-transcription	NULL
factor	NULL
Abs	NULL
,	NULL
when	NULL
the	NULL
membranes	NULL
quickly	NULL
reseal	NULL
,	NULL
intracellular	NULL
incorporation	NULL
of	NULL
the	NULL
Abs	NULL
occurs	NULL
.	NULL

This	NULL
procedure	NULL
maintains	NULL
functional	NULL
integrity	NULL
of	NULL
the	NULL
scraped	NULL
cells	NULL
,	NULL
while	NULL
incorporating	NULL
sufficient	NULL
quantities	NULL
of	NULL
Ig	NULL
for	NULL
the	NULL
subsequent	NULL
analysis	NULL
of	NULL
effects	NULL
on	NULL
specific	NULL
T	NULL
lymphocyte	NULL
activation	NULL
pathways	NULL
.	NULL

Coupling	NULL
this	NULL
procedure	NULL
with	NULL
methods	NULL
involving	NULL
multicolor	NULL
FACS	NULL
analysis	NULL
of	NULL
cell	NULL
surface	NULL
molecules	NULL
and	NULL
intracellular	NULL
cytokines	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
within	NULL
6	NULL
h	NULL
of	NULL
coactivation	NULL
,	NULL
intracellular	NULL
production	NULL
of	NULL
IL-2	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
Abs	NULL
to	NULL
components	NULL
of	NULL
the	NULL
AP-1	NULL
transcriptional	NULL
complex	NULL
in	NULL
the	NULL
initial	NULL
activation	NULL
of	NULL
resting	NULL
human	NULL
naive	NULL
and	NULL
memory	NULL
T	NULL
lymphocyte	NULL
subpopulations	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Reagents	NULL
PMA	NULL
,	NULL
ionomycin	NULL
,	NULL
BSA	NULL
,	NULL
and	NULL
poly-L-lysine	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

mAbs	NULL
rat	NULL
anti-human	NULL
IL-2	NULL
PE	NULL
(	NULL
IgG2a	NULL
)	NULL
,	NULL
mouse	NULL
anti-human	NULL
CD45RO	NULL
FITC	NULL
(	NULL
IgG2a	NULL
)	NULL
,	NULL
mouse	NULL
anti-human	NULL
CD4	NULL
Cychrome	NULL
(	NULL
IgG1	NULL
)	NULL
,	NULL
control	NULL
mouse	NULL
IgG2a	NULL
FITC	NULL
,	NULL
control	NULL
rat	NULL
IgG2a	NULL
PE	NULL
,	NULL
and	NULL
control	NULL
mouse	NULL
IgG1	NULL
Cychrome	NULL
were	NULL
all	NULL
purchased	NULL
from	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Mouse	NULL
anti-human	NULL
CD28	NULL
mAb	NULL
Leu28	NULL
was	NULL
purchased	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
Lincoln	NULL
Park	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

The	NULL
mouse	NULL
anti-human	NULL
CD3	NULL
mAb	NULL
OKT3	NULL
hybridoma	NULL
was	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
,	NULL
and	NULL
Ig	NULL
was	NULL
purified	NULL
from	NULL
ascites	NULL
.	NULL

Mouse	NULL
anti-human	NULL
;	NULL
integrin	NULL
mAb	NULL
33B6	NULL
was	NULL
generated	NULL
in	NULL
this	NULL
laboratory	NULL
and	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Goat	NULL
anti-rabbit	NULL
(	NULL
GAR	NULL
)	NULL
-FITC	NULL
was	NULL
purchased	NULL
from	NULL
PharMingen	NULL
.	NULL

Polyclonal	NULL
transcription	NULL
factor	NULL
Abs	NULL
used	NULL
were	NULL
rabbit	NULL
anti-c-Fos	NULL
(	NULL
Oncogene	NULL
Science	NULL
,	NULL
Uniondale	NULL
,	NULL
NY	NULL
)	NULL
and	NULL
rabbit	NULL
anti-c-Jun	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Rabbit	NULL
anti-mouse	NULL
Ig	NULL
was	NULL
purchased	NULL
from	NULL
Cappel	NULL
(	NULL
Durham	NULL
,	NULL
NC	NULL
)	NULL
.	NULL

The	NULL
extracellular	NULL
matrix	NULL
component	NULL
fibronectin	NULL
(	NULL
FN	NULL
)	NULL
was	NULL
affinity	NULL
purified	NULL
from	NULL
200	NULL
ml	NULL
of	NULL
human	NULL
plasma	NULL
(	NULL
Gulf	NULL
Coast	NULL
Regional	NULL
Blood	NULL
Center	NULL
,	NULL
Houston	NULL
,	NULL
TX	NULL
)	NULL
,	NULL
as	NULL
follows	NULL
.	NULL

Briefly	NULL
,	NULL
gelatin-Sepharose	NULL
columns	NULL
were	NULL
pre-washed	NULL
with	NULL
PBS	NULL
containing	NULL
2	NULL
mM	NULL
EDTA	NULL
and	NULL
0.1	NULL
mM	NULL
PMSF	NULL
.	NULL

Plasma	NULL
containing	NULL
2	NULL
mM	NULL
EDTA	NULL
and	NULL
0.1	NULL
mM	NULL
PMSF	NULL
was	NULL
passed	NULL
over	NULL
the	NULL
column	NULL
twice	NULL
and	NULL
then	NULL
washed	NULL
with	NULL
4	NULL
vol	NULL
PBS/EDTA/PMSF	NULL
.	NULL

Elution	NULL
of	NULL
FN	NULL
from	NULL
the	NULL
columns	NULL
was	NULL
performed	NULL
with	NULL
4	NULL
M	NULL
urea	NULL
in	NULL
0.15	NULL
M	NULL
NaCl	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
20	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8	NULL
.	NULL

Collected	NULL
fractions	NULL
were	NULL
dialyzed	NULL
into	NULL
PBS	NULL
.	NULL

All	NULL
procedures	NULL
were	NULL
conducted	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Purity	NULL
was	NULL
determined	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Cells	NULL
PB-T	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
negative	NULL
selection	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
buffy	NULL
coats	NULL
(	NULL
Gulf	NULL
Coast	NULL
Regional	NULL
Blood	NULL
Center	NULL
)	NULL
of	NULL
healthy	NULL
donors	NULL
by	NULL
density-dependent	NULL
cell	NULL
separation	NULL
on	NULL
Ficoll	NULL
(	NULL
1.077	NULL
g/ml	NULL
;	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
removed	NULL
by	NULL
several	NULL
rounds	NULL
of	NULL
plastic	NULL
adherence	NULL
on	NULL
tissue	NULL
culture	NULL
dishes	NULL
(	NULL
Costar	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
in	NULL
complete	NULL
media	NULL
(	NULL
RPMI	NULL
1640	NULL
,	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
v/v	NULL
FBS	NULL
,	NULL
1	NULL
mM	NULL
L-glutamine	NULL
,	NULL
50	NULL
U/ml	NULL
penicillin	NULL
,	NULL
and	NULL
50	NULL
U/ml	NULL
streptomycin	NULL
,	NULL
all	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Further	NULL
density-dependent	NULL
cell	NULL
separation	NULL
was	NULL
performed	NULL
on	NULL
discontinuous	NULL
Percoll	NULL
(	NULL
295	NULL
mOsm	NULL
;	NULL
Sigma	NULL
)	NULL
gradients	NULL
(	NULL
44	NULL
,	NULL
48	NULL
,	NULL
and	NULL
60	NULL
%	NULL
v/v	NULL
Percoll	NULL
in	NULL
RPMI	NULL
1640	NULL
;	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

Cells	NULL
at	NULL
the	NULL
interface	NULL
of	NULL
the	NULL
48/60	NULL
%	NULL
layer	NULL
were	NULL
carefully	NULL
collected	NULL
and	NULL
washed	NULL
in	NULL
complete	NULL
media	NULL
,	NULL
and	NULL
the	NULL
B	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
adherence	NULL
to	NULL
nylon	NULL
wool	NULL
(	NULL
Polysciences	NULL
,	NULL
Warrington	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

The	NULL
lymphocyte	NULL
population	NULL
obtained	NULL
this	NULL
way	NULL
was	NULL
routinely	NULL
>	NULL
95	NULL
%	NULL
CD3	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
flow-cytometric	NULL
analysis	NULL
(	NULL
Epics	NULL
Profile	NULL
,	NULL
Coulter	NULL
,	NULL
Miami	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Purified	NULL
T	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
complete	NULL
media	NULL
at	NULL
37°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
and	NULL
were	NULL
used	NULL
within	NULL
24	NULL
h	NULL
of	NULL
isolation	NULL
.	NULL

Protein	NULL
immobilization	NULL
For	NULL
costimulation	NULL
of	NULL
proliferation	NULL
,	NULL
50	NULL
pl	NULL
of	NULL
1	NULL
ug/ml	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
was	NULL
added	NULL
to	NULL
96-well	NULL
plates	NULL
(	NULL
Corning	NULL
Easy	NULL
Wash	NULL
ELISA	NULL
plates	NULL
,	NULL
Corning	NULL
,	NULL
NY	NULL
)	NULL
in	NULL
0.1	NULL
M	NULL
NaHCO	NULL
,	NULL
(	NULL
pH	NULL
8	NULL
)	NULL
.	NULL

Then	NULL
50	NULL
l	NULL
of	NULL
costimulatory	NULL
mAb	NULL
Leu28	NULL
(	NULL
anti-CD28	NULL
)	NULL
,	NULL
or	NULL
33B6	NULL
(	NULL
anti-B	NULL
;	NULL
integrin	NULL
)	NULL
,	NULL
or	NULL
the	NULL
extracellular	NULL
matrix	NULL
component	NULL
FN	NULL
(	NULL
all	NULL
at	NULL
4	NULL
ug/ml	NULL
in	NULL
0.1	NULL
M	NULL
NaHCO	NULL
,	NULL
,	NULL
pH	NULL
8	NULL
)	NULL
was	NULL
added	NULL
.	NULL

This	NULL
was	NULL
incubated	NULL
for	NULL
at	NULL
least	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

BSA	NULL
(	NULL
2	NULL
%	NULL
w/v	NULL
)	NULL
was	NULL
then	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

For	NULL
costimulation	NULL
of	NULL
cytokine	NULL
production	NULL
,	NULL
35-mm	NULL
bacteriologic	NULL
petri	NULL
dishes	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
were	NULL
precoated	NULL
with	NULL
1	NULL
pg/ml	NULL
OKT3	NULL
and	NULL
4	NULL
pg/ml	NULL
Leu28	NULL
in	NULL
0.05	NULL
M	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
9.5	NULL
)	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
1.5	NULL
ml	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Plates	NULL
were	NULL
then	NULL
blocked	NULL
with	NULL
2	NULL
%	NULL
w/v	NULL
BSA	NULL
for	NULL
1	NULL
h.	NULL
Plates	NULL
and	NULL
dishes	NULL
were	NULL
washed	NULL
extensively	NULL
in	NULL
PBS	NULL
before	NULL
use	NULL
.	NULL

T	NULL
cell	NULL
costimulation	NULL
of	NULL
proliferation	NULL
PB-T	NULL
cells	NULL
were	NULL
plated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
cells/well	NULL
)	NULL
in	NULL
triplicate	NULL
,	NULL
in	NULL
96-well	NULL
plates	NULL
that	NULL
were	NULL
precoated	NULL
with	NULL
appropriate	NULL
costimulatory	NULL
reagents	NULL
.	NULL

Approximately	NULL
2	NULL
to	NULL
3	NULL
days	NULL
after	NULL
initial	NULL
plating	NULL
,	NULL
cells	NULL
were	NULL
pulsed	NULL
with	NULL
0.5	NULL
Ci	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
complete	NULL
medium	NULL
.	NULL

After	NULL
a	NULL
24-h	NULL
incubation	NULL
period	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
onto	NULL
glass	NULL
fiber	NULL
filter	NULL
mats	NULL
(	NULL
Whatman	NULL
,	NULL
Maidstone	NULL
,	NULL
U.K.	NULL
)	NULL
using	NULL
a	NULL
PHD	NULL
cell	NULL
harvester	NULL
(	NULL
Cambridge	NULL
Technology	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
}	NULL
.	NULL

[	NULL
PH	NULL
]	NULL
Thymidine	NULL
incorporation	NULL
was	NULL
measured	NULL
via	NULL
standard	NULL
liquid	NULL
scintillation	NULL
counting	NULL
(	NULL
Beckman	NULL
LS2800	NULL
;	NULL
Beckman	NULL
Instruments	NULL
,	NULL
Fullerton	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Intracellular	NULL
cytokine	NULL
measurements	NULL
Cells	NULL
were	NULL
resuspended	NULL
in	NULL
complete	NULL
media	NULL
containing	NULL
4	NULL
uM	NULL
monensin	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
then	NULL
plated	NULL
in	NULL
12-well	NULL
tissue	NULL
culture	NULL
plates	NULL
for	NULL
PMA/ionomycin	NULL
activation	NULL
or	NULL
35-mm	NULL
bacteriologic	NULL
petri	NULL
dishes	NULL
that	NULL
had	NULL
been	NULL
precoated	NULL
with	NULL
the	NULL
appropriate	NULL
costimulatory	NULL
mAbs	NULL
.	NULL

After	NULL
6	NULL
h	NULL
of	NULL
activation	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
intracellular	NULL
cytokine	NULL
production	NULL
was	NULL
measured	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
to	NULL
be	NULL
stained	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
PBS	NULL
containing	NULL
1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
FBS	NULL
and	NULL
0.1	NULL
%	NULL
NaN	NULL
,	NULL
(	NULL
stain/wash	NULL
buffer	NULL
)	NULL
.	NULL

When	NULL
three-color	NULL
cell	NULL
staining	NULL
was	NULL
performed	NULL
,	NULL
directly	NULL
conjugated	NULL
Abs	NULL
were	NULL
added	NULL
,	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
then	NULL
washed	NULL
twice	NULL
in	NULL
stain/wash	NULL
buffer	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
fixed	NULL
in	NULL
2	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
formaldehyde	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

For	NULL
intracellular	NULL
staining	NULL
,	NULL
cells	NULL
were	NULL
then	NULL
permeabilized	NULL
by	NULL
washing	NULL
once	NULL
and	NULL
resuspending	NULL
with	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
saponin	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
1	NULL
%	NULL
FBS	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
NaN	NULL
,	NULL
in	NULL
PBS	NULL
(	NULL
permeabilization	NULL
bufl-er	NULL
)	NULL
.	NULL

Rat	NULL
anti-human	NULL
IL-2	NULL
PE	NULL
was	NULL
then	NULL
added	NULL
.	NULL

After	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
cells	NULL
were	NULL
again	NULL
washed	NULL
in	NULL
permeabilization	NULL
buffer	NULL
twice	NULL
and	NULL
once	NULL
in	NULL
stain/wash	NULL
buffer	NULL
,	NULL
then	NULL
read	NULL
on	NULL
an	NULL
Epics	NULL
Profile	NULL
flow	NULL
cytometer	NULL
(	NULL
Coulter	NULL
,	NULL
Miami	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Control	NULL
staining	NULL
was	NULL
performed	NULL
with	NULL
directly	NULL
conjugated	NULL
isotype-	NULL
and	NULL
flu-orochrome-matched	NULL
Ig	NULL
,	NULL
and	NULL
a	NULL
minimum	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
events	NULL
was	NULL
counted	NULL
per	NULL
test	NULL
sample	NULL
.	NULL

Scrape	NULL
loading	NULL
Bacteriologic	NULL
petri	NULL
dishes	NULL
(	NULL
35	NULL
mm	NULL
)	NULL
were	NULL
coated	NULL
with	NULL
poly-L-lysine	NULL
(	NULL
20	NULL
ug/tol	NULL
)	NULL
in	NULL
PBS	NULL
for	NULL
at	NULL
least	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
then	NULL
blocked	NULL
with	NULL
2	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
BSA	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
and	NULL
resuspended	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
the	NULL
indicated	NULL
treatments	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
then	NULL
plated	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
onto	NULL
PBS-washed	NULL
poly-L-lysine	NULL
dishes	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
indicated	NULL
temperatures	NULL
.	NULL

Almost	NULL
all	NULL
of	NULL
the	NULL
cells	NULL
became	NULL
firmly	NULL
attached	NULL
within	NULL
this	NULL
time	NULL
frame	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

After	NULL
the	NULL
30-min	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
removed	NULL
physically	NULL
from	NULL
the	NULL
surface	NULL
with	NULL
a	NULL
cell	NULL
scraper	NULL
(	NULL
Costar	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
500	NULL
ul	NULL
of	NULL
RPMI	NULL
1640	NULL
containing	NULL
the	NULL
test	NULL
reagents	NULL
or	NULL
controls	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
then	NULL
collected	NULL
and	NULL
placed	NULL
in	NULL
a	NULL
37°C	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
humidified	NULL
incubator	NULL
for	NULL
at	NULL
least	NULL
1	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
washed	NULL
once	NULL
in	NULL
complete	NULL
medium	NULL
and	NULL
used	NULL
for	NULL
tests	NULL
.	NULL

All	NULL
Abs	NULL
for	NULL
scrape	NULL
loading	NULL
were	NULL
used	NULL
at	NULL
50	NULL
pg/ml	NULL
,	NULL
unless	NULL
otherwise	NULL
noted	NULL
.	NULL

Control	NULL
buffers	NULL
for	NULL
scrape	NULL
loading	NULL
were	NULL
identical	NULL
with	NULL
the	NULL
formulation	NULL
in	NULL
which	NULL
commercial	NULL
Abs	NULL
were	NULL
resuspended	NULL
.	NULL

Results	NULL
Scrape	NULL
loading	NULL
of	NULL
resting	NULL
T	NULL
lymphocytes	NULL
The	NULL
technique	NULL
of	NULL
scrape	NULL
loading	NULL
requires	NULL
firmly	NULL
adherent	NULL
cells	NULL
.	NULL

The	NULL
use	NULL
of	NULL
this	NULL
method	NULL
to	NULL
introduce	NULL
mAbs	NULL
inside	NULL
lymphocytes	NULL
is	NULL
problematic	NULL
because	NULL
,	NULL
in	NULL
general	NULL
,	NULL
PB-T	NULL
cells	NULL
exist	NULL
in	NULL
a	NULL
low	NULL
avidity	NULL
adhesive	NULL
state	NULL
.	NULL

Although	NULL
activation	NULL
treatments	NULL
such	NULL
as	NULL
cross-linking	NULL
the	NULL
TCR	NULL
or	NULL
the	NULL
addition	NULL
of	NULL
cytokines	NULL
or	NULL
chemokines	NULL
can	NULL
dramatically	NULL
increase	NULL
cell	NULL
adhesion	NULL
,	NULL
these	NULL
types	NULL
of	NULL
protocols	NULL
had	NULL
to	NULL
be	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
651	NULL
FIGURE	NULL
1	NULL
.	NULL

Scrape	NULL
loading	NULL
of	NULL
GAR-FITC	NULL
into	NULL
freshly	NULL
isolated	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
.	NULL

PB-T	NULL
cells	NULL
were	NULL
scrape	NULL
loaded	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
with	NULL
GAR-FITC	NULL
(	NULL
100	NULL
pg/ml	NULL
)	NULL
on	NULL
BSA	NULL
(	NULL
nonadherent	NULL
substrate	NULL
,	NULL
gray	NULL
histograms	NULL
)	NULL
or	NULL
poly-L-lysine	NULL
(	NULL
adhesive	NULL
substrate	NULL
,	NULL
black	NULL
histograms	NULL
)	NULL
at	NULL
indicated	NULL
temperatures	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
.	NULL

CELL	NULL
NUMBER	NULL
avoided	NULL
because	NULL
they	NULL
would	NULL
interfere	NULL
with	NULL
the	NULL
later	NULL
goal	NULL
of	NULL
studying	NULL
processes	NULL
involved	NULL
in	NULL
driving	NULL
a	NULL
lymphocyte	NULL
from	NULL
the	NULL
resting	NULL
state	NULL
.	NULL

Since	NULL
we	NULL
had	NULL
shown	NULL
previously	NULL
that	NULL
T	NULL
lymphocyte	NULL
adhesion	NULL
to	NULL
poly-L-lysine	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
mAb	NULL
specific	NULL
for	NULL
the	NULL
CD3	NULL
complex	NULL
,	NULL
does	NULL
not	NULL
promote	NULL
T	NULL
cell	NULL
proliferation	NULL
or	NULL
induce	NULL
cytokine	NULL
production	NULL
(	NULL
18	NULL
)	NULL
,	NULL
poly-L-lysine	NULL
was	NULL
chosen	NULL
as	NULL
a	NULL
nonspecific	NULL
cell	NULL
attachment	NULL
factor	NULL
for	NULL
the	NULL
scrape	NULL
loading	NULL
of	NULL
resting	NULL
T	NULL
lymphocytes	NULL
.	NULL

After	NULL
washing	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
1	NULL
ml	NULL
of	NULL
freshly	NULL
isolated	NULL
human	NULL
PB-T	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
was	NULL
plated	NULL
on	NULL
poly-L-lysine-	NULL
or	NULL
BSA-precoated	NULL
dishes	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
(	NULL
4°C	NULL
)	NULL
,	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
20°C	NULL
)	NULL
,	NULL
or	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
fluoresceinated	NULL
IgG	NULL
(	NULL
GAR-FITC	NULL
,	NULL
100	NULL
pg/ml	NULL
!	NULL
)	NULL

to	NULL
indicate	NULL
scrape-loading	NULL
efficiency	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
removed	NULL
physically	NULL
from	NULL
the	NULL
petri	NULL
dish	NULL
surface	NULL
with	NULL
a	NULL
cell	NULL
scraper	NULL
.	NULL

Once	NULL
scraping	NULL
was	NULL
complete	NULL
,	NULL
cells	NULL
were	NULL
transferred	NULL
to	NULL
a	NULL
37°C	NULL
humidified	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
incubator	NULL
for	NULL
2	NULL
h.	NULL
Cellular	NULL
incorporation	NULL
of	NULL
GAR-FITC	NULL
was	NULL
measured	NULL
by	NULL
FACS	NULL
analysis	NULL
,	NULL
and	NULL
shown	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

T	NULL
cells	NULL
scrape	NULL
loaded	NULL
on	NULL
poly-L-lysine	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
black	NULL
histograms	NULL
)	NULL
incorporated	NULL
Ig	NULL
at	NULL
all	NULL
temperatures	NULL
,	NULL
whereas	NULL
cells	NULL
plated	NULL
in	NULL
the	NULL
BSA-coated	NULL
dishes	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
gray	NULL
histograms	NULL
)	NULL
did	NULL
not	NULL
demonstrate	NULL
any	NULL
increase	NULL
in	NULL
fluorescent	NULL
staining	NULL
over	NULL
controls	NULL
.	NULL

Control	NULL
staining	NULL
was	NULL
performed	NULL
by	NULL
mixing	NULL
GAR-FITC	NULL
(	NULL
100	NULL
ug/	NULL
ml	NULL
)	NULL
with	NULL
cells	NULL
without	NULL
scraping	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
this	NULL
representative	NULL
experiment	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
scrape	NULL
loading	NULL
at	NULL
4°C	NULL
demonstrated	NULL
cells	NULL
were	NULL
15.9	NULL
%	NULL
positive	NULL
for	NULL
GAR-FITC	NULL
,	NULL
and	NULL
the	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
(	NULL
MFT	NULL
)	NULL
increased	NULL
from	NULL
0.58	NULL
to	NULL
1.16	NULL
after	NULL
scrape	NULL
loading	NULL
.	NULL

However	NULL
,	NULL
maximal	NULL
GAR-FITC	NULL
was	NULL
incorporated	NULL
into	NULL
PB-T	NULL
cells	NULL
when	NULL
the	NULL
loading	NULL
was	NULL
performed	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
MFI	NULL
increased	NULL
from	NULL
0.62	NULL
to	NULL
3.40	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
positive	NULL
was	NULL
41.8	NULL
.	NULL

Although	NULL
there	NULL
was	NULL
apparent	NULL
heterogeneity	NULL
in	NULL
the	NULL
incorporation	NULL
of	NULL
GAR-FITC	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
complex	NULL
histograms	NULL
of	NULL
Figure	NULL
1	NULL
,	NULL
measurement	NULL
of	NULL
relative	NULL
uptake	NULL
of	NULL
GAR-FITC	NULL
by	NULL
different	NULL
PB-T	NULL
cell	NULL
subpopulations	NULL
did	NULL
not	NULL
indicate	NULL
substantial	NULL
differences	NULL
.	NULL

For	NULL
example	NULL
,	NULL
52	NULL
%	NULL
of	NULL
the	NULL
CD4	NULL
*	NULL
population	NULL
incorporated	NULL
GAR-FITC	NULL
with	NULL
a	NULL
MFI	NULL
of	NULL
8	NULL
,	NULL
the	NULL
CD4~_	NULL
population	NULL
was	NULL
43.4	NULL
%	NULL
with	NULL
a	NULL
MFI	NULL
of	NULL
9.1	NULL
,	NULL
the	NULL
CD45SRO	NULL
*	NULL
population	NULL
was	NULL
51.5	NULL
%	NULL
with	NULL
a	NULL
MFI	NULL
of	NULL
8.9	NULL
,	NULL
and	NULL
the	NULL
CD45RO	NULL
~	NULL
population	NULL
was	NULL
54.6	NULL
%	NULL
with	NULL
a	NULL
MFI	NULL
of	NULL
8.1	NULL
.	NULL

Digital	NULL
fluorescent	NULL
images	NULL
of	NULL
cells	NULL
scrape	NULL
loaded	NULL
on	NULL
poly-L-lysine	NULL
indicated	NULL
intracellular	NULL
incorporation	NULL
of	NULL
GAR-FITC	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
cells	NULL
that	NULL
were	NULL
scrape	NULL
loaded	NULL
on	NULL
BSA	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Exposure	NULL
times	NULL
for	NULL
both	NULL
images	NULL
were	NULL
identical	NULL
.	NULL

This	NULL
staining	NULL
pattern	NULL
in	NULL
Figure	NULL
2B	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
intracellular	NULL
vital	NULL
dyes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
scrape	NULL
loading	NULL
is	NULL
a	NULL
rapid	NULL
method	NULL
to	NULL
intracellularly	NULL
incorporate	NULL
macromolecules	NULL
such	NULL
as	NULL
Ig	NULL
into	NULL
freshly	NULL
isolated	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Physical	NULL
parameters	NULL
and	NULL
recovery	NULL
after	NULL
scrape	NULL
loading	NULL
of	NULL
PB-T	NULL
cells	NULL
One	NULL
hour	NULL
after	NULL
cells	NULL
were	NULL
scrape	NULL
loaded	NULL
with	NULL
GAR-FITC	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
fixed	NULL
in	NULL
2	NULL
%	NULL
formaldehyde	NULL
,	NULL
and	NULL
physical	NULL
parameters	NULL
such	NULL
as	NULL
size	NULL
and	NULL
granularity	NULL
were	NULL
measured	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
for	NULL
three	NULL
different	NULL
temperatures	NULL
in	NULL
Figure	NULL
3A	NULL
,	NULL
size	NULL
as	NULL
measured	NULL
by	NULL
forward	NULL
light	NULL
scatter	NULL
(	NULL
FLS	NULL
)	NULL
,	NULL
and	NULL
granularity	NULL
as	NULL
measured	NULL
by	NULL
side	NULL
15.9	NULL
%	NULL
+*	NULL
20°C	NULL
37.4	NULL
%	NULL
||	NULL
37°C	NULL
41.8	NULL
%	NULL
FLUORESCENCE	NULL
INTENSITY	NULL
(	NULL
log	NULL
)	NULL
light	NULL
scatter	NULL
(	NULL
SLS	NULL
)	NULL
remained	NULL
unchanged	NULL
for	NULL
cells	NULL
that	NULL
were	NULL
scraped	NULL
off	NULL
poly-L-lysine-coated	NULL
petri	NULL
dishes	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
nonscraped	NULL
cells	NULL
removed	NULL
from	NULL
BSA-coated	NULL
petri	NULL
dishes	NULL
.	NULL

Fixation	NULL
with	NULL
formaldehyde	NULL
did	NULL
not	NULL
change	NULL
these	NULL
physical	NULL
parameters	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
unfixed	NULL
samples	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Recovery	NULL
of	NULL
viable	NULL
scraped	NULL
cells	NULL
was	NULL
also	NULL
measured	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Approximately	NULL
70	NULL
%	NULL
of	NULL
the	NULL
initial	NULL
input	NULL
population	NULL
of	NULL
cells	NULL
were	NULL
recovered	NULL
,	NULL
and	NULL
almost	NULL
all	NULL
cells	NULL
were	NULL
viable	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
when	NULL
cells	NULL
are	NULL
scraped	NULL
at	NULL
both	NULL
20°C	NULL
and	NULL
37°C	NULL
,	NULL
while	NULL
approximately	NULL
40	NULL
%	NULL
of	NULL
the	NULL
input	NULL
cells	NULL
were	NULL
recovered	NULL
viable	NULL
at	NULL
4°C	NULL
.	NULL

Thus	NULL
,	NULL
relatively	NULL
high	NULL
yields	NULL
of	NULL
scraped	NULL
cells	NULL
can	NULL
be	NULL
recovered	NULL
at	NULL
the	NULL
optimal	NULL
temperature	NULL
for	NULL
scrape	NULL
loading	NULL
(	NULL
37°C	NULL
)	NULL
,	NULL
with	NULL
no	NULL
observed	NULL
differences	NULL
in	NULL
the	NULL
physical	NULL
parameters	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

Scrape-loaded	NULL
cells	NULL
retain	NULL
functional	NULL
activity	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
costimulation	NULL
of	NULL
proliferation	NULL
and	NULL
production	NULL
of	NULL
IL-2	NULL
The	NULL
technique	NULL
of	NULL
scrape	NULL
loading	NULL
is	NULL
a	NULL
valuable	NULL
tool	NULL
only	NULL
if	NULL
the	NULL
functional	NULL
integrity	NULL
of	NULL
the	NULL
scraped	NULL
cells	NULL
remains	NULL
intact	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
method	NULL
of	NULL
scrape	NULL
loading	NULL
would	NULL
have	NULL
deleterious	NULL
effects	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
be	NULL
activated	NULL
,	NULL
costimulation	NULL
tests	NULL
were	NULL
performed	NULL
on	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
scrape	NULL
loaded	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
control	NULL
,	NULL
soluble	NULL
protein	NULL
(	NULL
50	NULL
ug/ml	NULL
BSA	NULL
)	NULL
.	NULL

Known	NULL
costimulators	NULL
of	NULL
T	NULL
cell	NULL
proliferation	NULL
such	NULL
as	NULL
CD28	NULL
and	NULL
B	NULL
,	NULL
integrins	NULL
were	NULL
tested	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
costimulate	NULL
T	NULL
cells	NULL
when	NULL
coimmobilized	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
.	NULL

As	NULL
Figure	NULL
4A	NULL
demonstrates	NULL
,	NULL
cells	NULL
costimulated	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
in	NULL
conjunction	NULL
with	NULL
anti-CD28	NULL
,	NULL
FN	NULL
,	NULL
or	NULL
anti-	NULL
$	NULL
,	NULL
integrin	NULL
were	NULL
unaffected	NULL
by	NULL
the	NULL
technique	NULL
of	NULL
scrape	NULL
loading	NULL
,	NULL
as	NULL
there	NULL
was	NULL
no	NULL
real	NULL
difference	NULL
between	NULL
proliferation	NULL
of	NULL
)	NULL
C	NULL
A	NULL
|	NULL
ho	NULL
£2	NULL
o	NULL
0	NULL
a	NULL
G	NULL
s	NULL
Ws	NULL
o	NULL
``	NULL
o	NULL
Jo	NULL
FIGURE	NULL
2	NULL
.	NULL

T	NULL
cells	NULL
scrape	NULL
loaded	NULL
with	NULL
fluorescent	NULL
Ab	NULL
.	NULL

PB-T	NULL
cells	NULL
were	NULL
plated	NULL
on	NULL
BSA	NULL
(	NULL
A	NULL
)	NULL
or	NULL
poly-L-lysine	NULL
(	NULL
B	NULL
)	NULL
and	NULL
scraped	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GAR-FITC	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Bright	NULL
field	NULL
images	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
,	NULL
and	NULL
fluorescent	NULL
images	NULL
on	NULL
the	NULL
right	NULL
.	NULL

Digital	NULL
images	NULL
were	NULL
obtained	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Original	NULL
magnification	NULL
was	NULL
X400	NULL
,	NULL
and	NULL
equal	NULL
exposure	NULL
time	NULL
was	NULL
used	NULL
for	NULL
both	NULL
images	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
652	NULL
CD28/CD3	NULL
COSTIMULATION	NULL
OF	NULL
PRIMARY	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
REQUIRES	NULL
AP-1	NULL
Scraped	NULL
Eu	NULL
4°C	NULL
0	NULL
64	NULL
0	NULL
64	NULL
SLS	NULL
J	NULL
RECOVERY	NULL
(	NULL
%	NULL
)	NULL
4	NULL
20	NULL
37	NULL
TEMPERATURE	NULL
(	NULL
°C	NULL
)	NULL
FIGURE	NULL
3	NULL
.	NULL

Physical	NULL
parameters	NULL
remain	NULL
unchanged	NULL
and	NULL
cellular	NULL
recovery	NULL
is	NULL
high	NULL
after	NULL
scrape	NULL
loading	NULL
.	NULL

A	NULL
,	NULL
Forward	NULL
light	NULL
scatter	NULL
(	NULL
FLS	NULL
)	NULL
and	NULL
side	NULL
light	NULL
scatter	NULL
(	NULL
SLS	NULL
)	NULL
were	NULL
measured	NULL
on	NULL
an	NULL
Epics	NULL
profile	NULL
flow	NULL
cytometer	NULL
for	NULL
PB-T	NULL
cells	NULL
scraped	NULL
or	NULL
not	NULL
scraped	NULL
at	NULL
three	NULL
different	NULL
temperatures	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
of	NULL
three	NULL
is	NULL
shown	NULL
.	NULL

B	NULL
,	NULL
PB-T	NULL
cells	NULL
were	NULL
plated	NULL
on	NULL
BSA	NULL
or	NULL
poly-L-lysine	NULL
at	NULL
three	NULL
different	NULL
temperatures	NULL
and	NULL
scraped	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Cell	NULL
recovery	NULL
was	NULL
determined	NULL
by	NULL
dividing	NULL
the	NULL
number	NULL
of	NULL
trypan	NULL
blue	NULL
excluding	NULL
cells	NULL
recovered	NULL
after	NULL
scraping	NULL
cells	NULL
off	NULL
poly-L-lysine	NULL
by	NULL
the	NULL
initial	NULL
input	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Equal	NULL
numbers	NULL
of	NULL
cells	NULL
were	NULL
applied	NULL
to	NULL
both	NULL
conditions	NULL
.	NULL

Error	NULL
bars	NULL
are	NULL
the	NULL
SE	NULL
of	NULL
the	NULL
mean	NULL
and	NULL
represent	NULL
the	NULL
averages	NULL
from	NULL
two	NULL
separate	NULL
experiments	NULL
.	NULL

scrape-loaded	NULL
and	NULL
non-scrape-loaded	NULL
cells	NULL
.	NULL

Proliferation	NULL
assays	NULL
,	NULL
however	NULL
,	NULL
require	NULL
approximately	NULL
3	NULL
days	NULL
of	NULL
incubation	NULL
,	NULL
which	NULL
is	NULL
well	NULL
past	NULL
events	NULL
mediating	NULL
early	NULL
transcription	NULL
factor	NULL
induction	NULL
,	NULL
which	NULL
could	NULL
have	NULL
been	NULL
transiently	NULL
affected	NULL
by	NULL
the	NULL
scrape-loading	NULL
procedure	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
very	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
events	NULL
remain	NULL
functional	NULL
after	NULL
the	NULL
scrape-loading	NULL
manipulation	NULL
,	NULL
the	NULL
technique	NULL
of	NULL
intracellular	NULL
cytokine	NULL
staining	NULL
was	NULL
used	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Freshly	NULL
isolated	NULL
T	NULL
cells	NULL
were	NULL
scrape	NULL
loaded	NULL
on	NULL
poly-L-lysine	NULL
with	NULL
rabbit	NULL
anti-mouse	NULL
(	NULL
RAM	NULL
)	NULL
Ig	NULL
,	NULL
let	NULL
rest	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
then	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
ionomycin	NULL
(	NULL
2	NULL
pg/m	NULL
!	NULL
)	NULL

in	NULL
complete	NULL
media	NULL
containing	NULL
4	NULL
wM	NULL
monensin	NULL
.	NULL

After	NULL
6	NULL
h	NULL
of	NULL
incubation	NULL
in	NULL
a	NULL
humidified	NULL
37°C	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
incubator	NULL
,	NULL
cells	NULL
were	NULL
fixed	NULL
overnight	NULL
in	NULL
2	NULL
%	NULL
formaldehyde	NULL
at	NULL
4°C	NULL
.	NULL

Staining	NULL
for	NULL
intracellular	NULL
IL-2	NULL
was	NULL
performed	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Control	NULL
gating	NULL
was	NULL
set	NULL
with	NULL
fluorochrome/isotype-matched	NULL
controls	NULL
(	NULL
rat	NULL
IgG2a	NULL
PE	NULL
,	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
demonstrated	NULL
in	NULL
Figure	NULL
4B	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
,	NULL
20.3	NULL
%	NULL
of	NULL
the	NULL
scrape-loaded	NULL
cells	NULL
contained	NULL
detectable	NULL
intracellular	NULL
IL-2	NULL
within	NULL
6	NULL
h	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Unactivated	NULL
cells	NULL
scrape	NULL
loaded	NULL
with	NULL
RAM	NULL
demonstrated	NULL
no	NULL
intracellular	NULL
staining	NULL
for	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
demonstrates	NULL
that	NULL
the	NULL
physical	NULL
removal	NULL
of	NULL
T	NULL
cells	NULL
adherent	NULL
to	NULL
poly-L-lysine	NULL
with	NULL
the	NULL
concomitant	NULL
introduction	NULL
of	NULL
Ab	NULL
retains	NULL
T	NULL
cell	NULL
functionality	NULL
,	NULL
as	NULL
measured	NULL
through	NULL
the	NULL
costimulation	NULL
of	NULL
IL-2	NULL
production	NULL
.	NULL

Because	NULL
the	NULL
previous	NULL
experiment	NULL
was	NULL
performed	NULL
using	NULL
high	NULL
concentrations	NULL
of	NULL
pharmacologic	NULL
inducers	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
it	NULL
was	NULL
important	NULL
to	NULL
determine	NULL
whether	NULL
scrape	NULL
loading	NULL
influenced	NULL
early	NULL
events	NULL
in	NULL
T	NULL
lymphocytes	NULL
coactivated	NULL
under	NULL
more	NULL
relevant	NULL
circumstances	NULL
,	NULL
such	NULL
as	NULL
ligation	NULL
of	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
costimulatory	NULL
molecule	NULL
CD28	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
previous	NULL
experiment	NULL
dealt	NULL
with	NULL
a	NULL
purified	NULL
PB-T	NULL
cell	NULL
population	NULL
as	NULL
a	NULL
whole	NULL
,	NULL
rather	NULL
than	NULL
certain	NULL
discrete	NULL
lymphocyte	NULL
subsets	NULL
.	NULL

In	NULL
Figure	NULL
4C	NULL
(	NULL
summarized	NULL
in	NULL
Table	NULL
I	NULL
)	NULL
,	NULL
RAM	NULL
scrape-loaded	NULL
PB-T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
right	NULL
panels	NULL
,	NULL
top	NULL
and	NULL
bottom	NULL
)	NULL
were	NULL
compared	NULL
with	NULL
non-scrape-loaded	NULL
cells	NULL
(	NULL
middle	NULL
panels	NULL
,	NULL
top	NULL
and	NULL
bottom	NULL
)	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
CD3/CD28	NULL
costimulation	NULL
.	NULL

Three-color	NULL
flow	NULL
cytometry	NULL
was	NULL
used	NULL
to	NULL
analyze	NULL
intracellular	NULL
IL-2	NULL
accumulation	NULL
within	NULL
CD45RO	NULL
*~	NULL
and	NULL
CD4	NULL
*~	NULL
subpopulations	NULL
of	NULL
PB-T	NULL
lymphocytes	NULL
after	NULL
both	NULL
scraped	NULL
and	NULL
nonscraped	NULL
cells	NULL
were	NULL
activated	NULL
for	NULL
6	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4	NULL
uM	NULL
monensin	NULL
.	NULL

Gating	NULL
for	NULL
CD45RO	NULL
and	NULL
CD4	NULL
was	NULL
set	NULL
in	NULL
reference	NULL
to	NULL
fluorochrome/isotype-matched	NULL
control	NULL
Ig	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
left	NULL
panel	NULL
of	NULL
Figure	NULL
4C	NULL
(	NULL
``	NULL
control	NULL
stain	NULL
,	NULL
``	NULL
top	NULL
and	NULL
bottom	NULL
)	NULL
represents	NULL
background	NULL
fluorescence	NULL
of	NULL
the	NULL
CD4SRO	NULL
~	NULL
and	NULL
CD4	NULL
*~	NULL
cell	NULL
populations	NULL
.	NULL

These	NULL
had	NULL
been	NULL
stained	NULL
with	NULL
rat	NULL
IgG2a	NULL
PE	NULL
after	NULL
RAM	NULL
scrape	NULL
loading	NULL
,	NULL
and	NULL
CD3/CD28	NULL
costimulation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4	NULL
wM	NULL
monensin	NULL
,	NULL
therefore	NULL
,	NULL
serves	NULL
as	NULL
a	NULL
control	NULL
for	NULL
the	NULL
rat	NULL
anti-human	NULL
IL-2	NULL
IgG2a	NULL
PE	NULL
stains	NULL
.	NULL

Unactivated	NULL
cells	NULL
,	NULL
or	NULL
cells	NULL
plated	NULL
on	NULL
anti-CD3	NULL
mAb	NULL
alone	NULL
did	NULL
not	NULL
demonstrate	NULL
detectable	NULL
intracellular	NULL
IL-2	NULL
accumulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
population	NULL
of	NULL
T	NULL
cells	NULL
is	NULL
highly	NULL
purified	NULL
,	NULL
the	NULL
CD45RO_-	NULL
and	NULL
CD4~	NULL
populations	NULL
may	NULL
be	NULL
considered	NULL
as	NULL
CD45RA*	NULL
and	NULL
CD8	NULL
*	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
there	NULL
was	NULL
only	NULL
a	NULL
slight	NULL
effect	NULL
on	NULL
CD28/CD3	NULL
T	NULL
cell	NULL
coactivation	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
intracellular	NULL
IL-2	NULL
accumulation	NULL
due	NULL
to	NULL
the	NULL
scrape-loading	NULL
procedure	NULL
.	NULL

For	NULL
example	NULL
,	NULL
costimulation	NULL
caused	NULL
57.5	NULL
%	NULL
of	NULL
the	NULL
CD45RO	NULL
*	NULL
(	NULL
top	NULL
middle	NULL
panel	NULL
,	NULL
calculated	NULL
from	NULL
the	NULL
top	NULL
and	NULL
bottom	NULL
right	NULL
quadrants	NULL
)	NULL
subset	NULL
of	NULL
T	NULL
lymphocytes	NULL
to	NULL
become	NULL
positive	NULL
for	NULL
intracellular	NULL
IL-2	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

In	NULL
the	NULL
CD45RO	NULL
*	NULL
subset	NULL
that	NULL
had	NULL
been	NULL
scrape	NULL
loaded	NULL
with	NULL
RAM	NULL
(	NULL
top	NULL
right	NULL
panel	NULL
)	NULL
,	NULL
52.5	NULL
%	NULL
of	NULL
the	NULL
population	NULL
was	NULL
positive	NULL
for	NULL
intracellular	NULL
IL-2	NULL
after	NULL
costimulation	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

This	NULL
demonstrates	NULL
that	NULL
RAM	NULL
scrape-loaded	NULL
T	NULL
cells	NULL
retain	NULL
their	NULL
functional	NULL
integrity	NULL
and	NULL
can	NULL
immediately	NULL
be	NULL
used	NULL
for	NULL
studies	NULL
on	NULL
early	NULL
events	NULL
regulating	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Also	NULL
noteworthy	NULL
from	NULL
the	NULL
multiparameter	NULL
flow-cytometric	NULL
analysis	NULL
shown	NULL
in	NULL
Figure	NULL
4C	NULL
and	NULL
summarized	NULL
in	NULL
Table	NULL
I	NULL
is	NULL
that	NULL
costimulation	NULL
of	NULL
PB-T	NULL
cells	NULL
with	NULL
anti-CD3	NULL
and	NULL
anti-CD28	NULL
mAbs	NULL
demonstrates	NULL
that	NULL
IL-2	NULL
production	NULL
is	NULL
from	NULL
both	NULL
the	NULL
CD45RO*	NULL
(	NULL
memory	NULL
)	NULL
and	NULL
CD4SRO~_	NULL
(	NULL
naive	NULL
)	NULL
subpopulations	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
cells	NULL
responding	NULL
to	NULL
CD28/CD3	NULL
costimulation	NULL
is	NULL
usually	NULL
skewed	NULL
toward	NULL
the	NULL
CD45RO+*	NULL
and	NULL
CD4	NULL
*	NULL
subsets	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
this	NULL
were	NULL
a	NULL
general	NULL
phenomenon	NULL
,	NULL
PB-T	NULL
lymphocytes	NULL
from	NULL
12	NULL
different	NULL
donors	NULL
were	NULL
purified	NULL
and	NULL
tested	NULL
for	NULL
subpopulation	NULL
expression	NULL
of	NULL
IL-2	NULL
after	NULL
CD28/CD3	NULL
costimulation	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
results	NULL
obtained	NULL
in	NULL
the	NULL
RAM	NULL
scrape-loaded	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
,	NULL
unmanipulated	NULL
PB-T	NULL
lymphocytes	NULL
also	NULL
demonstrated	NULL
this	NULL
skewed	NULL
production	NULL
of	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
range	NULL
of	NULL
total	NULL
IL-2	NULL
production	NULL
between	NULL
the	NULL
donors	NULL
was	NULL
broad	NULL
,	NULL
averages	NULL
obtained	NULL
from	NULL
the	NULL
different	NULL
cell	NULL
subsets	NULL
displayed	NULL
a	NULL
distinct	NULL
pattern	NULL
of	NULL
IL-2	NULL
production	NULL
.	NULL

Upon	NULL
costimulation	NULL
by	NULL
CD28	NULL
and	NULL
CD3	NULL
mAbs	NULL
,	NULL
CD45RO	NULL
*	NULL
T	NULL
cells	NULL
on	NULL
average	NULL
were	NULL
43.4	NULL
%	NULL
(	NULL
range	NULL
=	NULL
13.1-79.2	NULL
)	NULL
positive	NULL
for	NULL
intracellular	NULL
IL-2	NULL
,	NULL
whereas	NULL
the	NULL
CD45RO~	NULL
subsets	NULL
were	NULL
on	NULL
average	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
D	NULL
>	NULL
653	NULL
80000	NULL
FIGURE	NULL
4	NULL
.	NULL

Scrape-loaded	NULL
PB-T	NULL
cells	NULL
maintain	NULL
functionality	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
costimulation	NULL
of	NULL
proliferation	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
production	NULL
.	NULL

A	NULL
,	NULL
Freshly	NULL
isolated	NULL
PB-T	NULL
cells	NULL
were	NULL
scrape	NULL
loaded	NULL
on	NULL
poly	NULL
--	NULL
lysine	NULL
(	NULL
gray	NULL
bars	NULL
)	NULL
and	NULL
compared	NULL
with	NULL
unscraped	NULL
cells	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
in	NULL
a	NULL
proliferation	NULL
assay	NULL
.	NULL

Proliferation	NULL
was	NULL
induced	NULL
by	NULL
coimmobiliza-tion	NULL
of	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
in	NULL
conjunction	NULL
with	NULL
anti-CD28	NULL
,	NULL
FN	NULL
,	NULL
or	NULL
anti-B	NULL
,	NULL
integrin	NULL
mAb	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
average	NULL
+	NULL
SEM	NULL
from	NULL
triplicate	NULL
determinations	NULL
.	NULL

B	NULL
,	NULL
Scraped	NULL
PB-T	NULL
cells	NULL
maintain	NULL
functional	NULL
re-	NULL
B	NULL
sponses	NULL
to	NULL
pharmacologic	NULL
activation	NULL
stimuli	NULL
.	NULL

Intracellular	NULL
IL-2	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
3	NULL
H-Tdr	NULL
Incorporation	NULL
(	NULL
cpm	NULL
)	NULL
O	NULL
L	NULL
R	NULL
No	NULL
Treatment	NULL
Cells	NULL
Scraped	NULL
NONE	NULL
No	NULL
activation	NULL
Anti-CD28	NULL
Fn	NULL
Costimulant	NULL
immobilized	NULL
with	NULL
OKT3	NULL
Anti-B1	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
+	NULL
lonomycin	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Unactivated	NULL
PB-T	NULL
cells	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
and	NULL
PB-T	NULL
cells	NULL
activated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
2	NULL
ug/	NULL
ml	NULL
)	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
were	NULL
intracellularly	NULL
stained	NULL
with	NULL
rat	NULL
anti-human	NULL
IL-2	NULL
directly	NULL
conjugated	NULL
to	NULL
PE	NULL
.	NULL

Both	NULL
groups	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4	NULL
M	NULL
monensin	NULL
during	NULL
the	NULL
activation	NULL
period	NULL
.	NULL

The	NULL
number	NULL
of	NULL
events	NULL
counted	NULL
was	NULL
greater	NULL
than	NULL
5	NULL
X	NULL
10	NULL
%	NULL
.	NULL

C	NULL
,	NULL
PB-T	NULL
cell	NULL
subsets	NULL
maintain	NULL
functionality	NULL
with	NULL
respect	NULL
to	NULL
costimulation	NULL
of	NULL
IL-2	NULL
production	NULL
by	NULL
CD3/	NULL
CD28	NULL
ligation	NULL
after	NULL
scrape	NULL
loading	NULL
of	NULL
non-	NULL
C	NULL
specific	NULL
RAM	NULL
Ig	NULL
.	NULL

RAM	NULL
scrape-loaded	NULL
PB-T	NULL
Cell	NULL
Number	NULL
Control	NULL
Stain	NULL
0.7	NULL
%	NULL
*	NULL
20.3	NULL
%	NULL
*	NULL
Intracellular	NULL
IL-2	NULL
Non-Scrape	NULL
loaded	NULL
Cells	NULL
RAM-Scrape	NULL
loaded	NULL
Cells	NULL
cells	NULL
(	NULL
right	NULL
panels	NULL
,	NULL
top	NULL
and	NULL
bottom	NULL
)	NULL
were	NULL
compared	NULL
with	NULL
nonscraped	NULL
cells	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
CD3/CD28	NULL
costimulation	NULL
.	NULL

Multiparameter	NULL
flow	NULL
cytometry	NULL
was	NULL
used	NULL
to	NULL
analyze	NULL
intracellular	NULL
IL-2	NULL
accumulation	NULL
within	NULL
CD4SRO	NULL
*~	NULL
and	NULL
CD4	NULL
*~	NULL
subpopulations	NULL
of	NULL
PB-T	NULL
lymphocytes	NULL
.	NULL

Gating	NULL
for	NULL
CD45RO	NULL
and	NULL
CD4	NULL
was	NULL
set	NULL
in	NULL
reference	NULL
to	NULL
fluorochrome/isotype-matched	NULL
control	NULL
Ig	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
left	NULL
panel	NULL
(	NULL
control	NULL
stain	NULL
,	NULL
top	NULL
and	NULL
bottom	NULL
)	NULL
represents	NULL
background	NULL
fluorescence	NULL
of	NULL
the	NULL
CD4SRO	NULL
*~	NULL
and	NULL
CD4*~	NULL
cell	NULL
IgGza	NULL
0.7	NULL
Cell	NULL
Surface	NULL
CD45RO	NULL
IntracellularIL-2	NULL
populations	NULL
stained	NULL
with	NULL
control	NULL
rat	NULL
IgG2a	NULL
PE	NULL
,	NULL
and	NULL
therefore	NULL
serves	NULL
as	NULL
a	NULL
control	NULL
for	NULL
the	NULL
rat	NULL
anti-human	NULL
IL-2	NULL
IgG2a	NULL
PE	NULL
.	NULL

A	NULL
minimum	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
events	NULL
was	NULL
counted	NULL
per	NULL
test	NULL
.	NULL

The	NULL
results	NULL
in	NULL
Figure	NULL
4C	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

77.7	NULL
]	NULL
2.9	NULL
<	NULL
19.2|0.2	NULL
[	NULL
a	NULL
)	NULL
O	NULL
©	NULL
8	NULL
or	NULL
'	NULL
C	NULL
3	NULL
P	NULL
+	NULL
©	NULL
0	NULL
3	NULL
IgGZa	NULL
Intracellular	NULL
IL-2	NULL
Table	NULL
I	NULL
.	NULL

__	NULL
PB-T	NULL
lymphocytes	NULL
retain	NULL
their	NULL
ability	NULL
to	NULL
be	NULL
constimulated	NULL
by	NULL
only	NULL
23.5	NULL
%	NULL
(	NULL
range	NULL
=	NULL
5.6-50	NULL
)	NULL
positive	NULL
(	NULL
p	NULL
<	NULL
0.0001	NULL
,	NULL
paired	NULL
Student	NULL
's	NULL
£	NULL
test	NULL
)	NULL
.	NULL

Likewise	NULL
for	NULL
CD4	NULL
*	NULL
subsets	NULL
,	NULL
the	NULL
average	NULL
percentage	NULL
of	NULL
cells	NULL
IL-2	NULL
positive	NULL
was	NULL
42.6	NULL
(	NULL
range	NULL
=	NULL
8.3-73.6	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
CD4~	NULL
cells	NULL
,	NULL
only	NULL
12.4	NULL
%	NULL
(	NULL
range	NULL
=	NULL
1.7-27.2	NULL
)	NULL
of	NULL
the	NULL
cells	NULL
on	NULL
average	NULL
were	NULL
IL-2	NULL
positive	NULL
(	NULL
p	NULL
<	NULL
0.0001	NULL
,	NULL
paired	NULL
Student	NULL
's	NULL
¢	NULL
test	NULL
)	NULL
.	NULL

In	NULL
no	NULL
donor	NULL
was	NULL
this	NULL
trend	NULL
not	NULL
apparent	NULL
.	NULL

Even	NULL
when	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
IL-2	NULL
produced	NULL
was	NULL
low	NULL
,	NULL
the	NULL
amount	NULL
always	NULL
conformed	NULL
to	NULL
the	NULL
rule	NULL
that	NULL
CD45RO+*	NULL
>	NULL
CD45RO~	NULL
,	NULL
and	NULL
CD4*	NULL
>	NULL
CD4~	NULL
.	NULL

Since	NULL
these	NULL
are	NULL
purified	NULL
populations	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
less	NULL
IL-2	NULL
was	NULL
produced	NULL
in	NULL
the	NULL
CD45RO-	NULL
and	NULL
CD4~	NULL
subsets	NULL
,	NULL
by	NULL
inference	NULL
the	NULL
CD45RA*	NULL
and	NULL
CD3	NULL
and	NULL
CD28	NULL
coligation	NULL
even	NULL
after	NULL
scrape-loading	NULL
of	NULL
Ram	NULL
%	NULL
of	NULL
Cells	NULL
Positive	NULL
for	NULL
IL-2	NULL
in	NULL
T	NULL
Cell	NULL
Subpopulations	NULL
``	NULL
Treatment	NULL
CD4SRO*	NULL
CD4SRO~	NULL
CD4+*	NULL
CD4	NULL
None	NULL
57.5	NULL
40.8	NULL
56.8	NULL
14.6	NULL
Scraped	NULL
52.5	NULL
37.3	NULL
50.9	NULL
11.5	NULL
``	NULL
The	NULL
percentage	NULL
of	NULL
cells	NULL
positive	NULL
for	NULL
IL-2	NULL
in	NULL
various	NULL
T	NULL
cells	NULL
subsets	NULL
was	NULL
calculated	NULL
according	NULL
to	NULL
the	NULL
following	NULL
formula	NULL
:	NULL
%	NULL
positive	NULL
=	NULL
[	NULL
(	NULL
IL-2	NULL
%	NULL
positive	NULL
for	NULL
given	NULL
subset	NULL
)	NULL
(	NULL
total	NULL
%	NULL
positive	NULL
of	NULL
given	NULL
subset	NULL
in	NULL
the	NULL
whole	NULL
population	NULL
)	NULL
]	NULL
X	NULL
100	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
654	NULL
Percentage	NULL
of	NULL
Cells	NULL
IL-2	NULL
Positive	NULL
CD28/CD3	NULL
COSTIMULATION	NULL
OF	NULL
PRIMARY	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
REQUIRES	NULL
AP-1	NULL
100	NULL
90	NULL
80	NULL
-	NULL
DO	NULL
[	NULL
A	NULL
70	NULL
-	NULL
Lal	NULL
Q	NULL
so|	NULL
-	NULL
°	NULL
8	NULL
re	NULL
x	NULL
so-	NULL
__	NULL
@	NULL
[	NULL
m	NULL
)	NULL
ao	NULL
-K-	NULL
43.4	NULL
@	NULL
-Q_-a2.6	NULL
$	NULL
a	NULL
y	NULL
30	NULL
—Q—	NULL
<	NULL
>	NULL
23.5	NULL
C	NULL
20	NULL
-	NULL
[	NULL
28	NULL
]	NULL
}	NULL
8	NULL
R	NULL
V	NULL
[	NULL
#	NULL
2	NULL
]	NULL
12.4	NULL
10-	NULL
g	NULL
é	NULL
0	NULL
i	NULL
t	NULL
T	NULL
CD45RO+	NULL
CD45RO-	NULL
CD4+	NULL
CD4-B	NULL
DONOR	NULL
A	NULL
M	NULL
'	NULL
O-i	NULL
65.7	NULL
]	NULL
33.4	NULL
Intracellular	NULL
IL-2	NULL
57.910.6	NULL
41.510.1	NULL
Cell	NULL
Surface	NULL
CD4	NULL
Intracellular	NULL
IL-2	NULL
DONOR	NULL
B	NULL
Intracellular	NULL
IL-2	NULL
Cell	NULL
Surface	NULL
CD8	NULL
Intracellular	NULL
IL-2	NULL
CD8*	NULL
subsets	NULL
should	NULL
produce	NULL
less	NULL
IL-2	NULL
than	NULL
CD45RA~	NULL
and	NULL
CD8~	NULL
subsets	NULL
,	NULL
respectively	NULL
.	NULL

This	NULL
is	NULL
in	NULL
fact	NULL
the	NULL
case	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
donor	NULL
A	NULL
,	NULL
IL-2	NULL
production	NULL
was	NULL
greatest	NULL
in	NULL
the	NULL
CD4S5RO®	NULL
and	NULL
CD4*	NULL
subpopulations	NULL
.	NULL

In	NULL
donor	NULL
B	NULL
,	NULL
in	NULL
which	NULL
CD4SRA	NULL
and	NULL
CD8	NULL
were	NULL
stained	NULL
instead	NULL
of	NULL
CD4SRO	NULL
and	NULL
CD4	NULL
,	NULL
IL-2	NULL
production	NULL
was	NULL
greatest	NULL
in	NULL
the	NULL
CD45RA~	NULL
and	NULL
CD8	NULL
subpopulations	NULL
.	NULL

Therefore	NULL
,	NULL
naive	NULL
cells	NULL
(	NULL
CD4SRO_-	NULL
or	NULL
RA	NULL
*	NULL
)	NULL
and	NULL
CD8	NULL
*	NULL
cells	NULL
generally	NULL
produce	NULL
less	NULL
IL-2	NULL
when	NULL
costimulated	NULL
with	NULL
CD28	NULL
and	NULL
CD3	NULL
.	NULL

CD28-dependent	NULL
costimulation	NULL
of	NULL
PB-T	NULL
cells	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
the	NULL
intracellular	NULL
accumulation	NULL
of	NULL
IL-2	NULL
,	NULL
is	NULL
inhibited	NULL
by	NULL
cyclosporin	NULL
A	NULL
As	NULL
demonstrated	NULL
in	NULL
previous	NULL
experiments	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
production	NULL
can	NULL
be	NULL
analyzed	NULL
readily	NULL
by	NULL
intracellular	NULL
staining	NULL
of	NULL
activated	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
this	NULL
procedure	NULL
requires	NULL
the	NULL
activation	NULL
of	NULL
PB-T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
monensin	NULL
,	NULL
which	NULL
stagnates	NULL
Golgi	NULL
transport	NULL
by	NULL
neutralizing	NULL
its	NULL
pH	NULL
.	NULL

In	NULL
so	NULL
doing	NULL
,	NULL
proteins	NULL
normally	NULL
secreted	NULL
can	NULL
accumulate	NULL
in	NULL
the	NULL
Golgi	NULL
and	NULL
endoplasmic	NULL
reticulum	NULL
,	NULL
augmenting	NULL
their	NULL
staining	NULL
signal	NULL
and	NULL
facilitating	NULL
FACS	NULL
analysis	NULL
.	NULL

It	NULL
was	NULL
not	NULL
clear	NULL
,	NULL
however	NULL
,	NULL
that	NULL
this	NULL
technique	NULL
would	NULL
be	NULL
adequate	NULL
to	NULL
measure	NULL
decreases	NULL
in	NULL
cytokine	NULL
production	NULL
if	NULL
the	NULL
amount	NULL
that	NULL
could	NULL
be	NULL
held	NULL
in	NULL
these	NULL
vesicles	NULL
was	NULL
limited	NULL
.	NULL

Therefore	NULL
,	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
coimmobilized	NULL
anti-CD3	NULL
and	NULL
anti-CD28	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
,	NULL
0.5	NULL
ug/ml	NULL
)	NULL
to	NULL
determine	NULL
whether	NULL
decreases	NULL
in	NULL
IL-2	NULL
levels	NULL
could	NULL
be	NULL
measured	NULL
after	NULL
6	NULL
h	NULL
of	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
for	NULL
CD45RO	NULL
and	NULL
intracellular	NULL
IL-2	NULL
.	NULL

As	NULL
summarized	NULL
in	NULL
Table	NULL
II	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
positive	NULL
for	NULL
IL-2	NULL
decreased	NULL
from	NULL
13.6	NULL
to	NULL
3.2	NULL
in	NULL
the	NULL
CsA-treated	NULL
group	NULL
of	NULL
the	NULL
CD45RO~	NULL
subset	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
represents	NULL
a	NULL
76.5	NULL
%	NULL
decrease	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
IL-2-positive	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
CD45RO	NULL
*	NULL
subpopulation	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
positive	NULL
for	NULL
IL-2	NULL
dropped	NULL
from	NULL
40	NULL
to	NULL
12.6	NULL
%	NULL
in	NULL
the	NULL
CsA-treated	NULL
cells	NULL
.	NULL

This	NULL
represented	NULL
a	NULL
68.5	NULL
%	NULL
decrease	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
IL-2-positive	NULL
cells	NULL
after	NULL
CsA	NULL
treatment	NULL
.	NULL

It	NULL
appeared	NULL
then	NULL
that	NULL
the	NULL
procedures	NULL
involved	NULL
in	NULL
activating	NULL
cells	NULL
for	NULL
intracellular	NULL
IL-2	NULL
staining	NULL
(	NULL
particularly	NULL
the	NULL
use	NULL
of	NULL
monensin	NULL
)	NULL
would	NULL
be	NULL
conducive	NULL
for	NULL
the	NULL
study	NULL
of	NULL
inhibition	NULL
of	NULL
IL-2	NULL
production	NULL
.	NULL

Inhibition	NULL
of	NULL
pharmacologic	NULL
(	NULL
PMA/ionomycin	NULL
)	NULL
and	NULL
physiologic	NULL
(	NULL
CD28/CD3	NULL
)	NULL
induction	NULL
of	NULL
IL-2	NULL
production	NULL
by	NULL
incorporation	NULL
of	NULL
a	NULL
mixture	NULL
of	NULL
Abs	NULL
specific	NULL
for	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
transcription	NULL
factors	NULL
Besides	NULL
its	NULL
own	NULL
consensus	NULL
site	NULL
,	NULL
AP-1	NULL
proteins	NULL
are	NULL
thought	NULL
to	NULL
associate	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
in	NULL
as	NULL
many	NULL
as	NULL
five	NULL
other	NULL
DNA	NULL
binding	NULL
sites	NULL
,	NULL
possibly	NULL
acting	NULL
as	NULL
a	NULL
master	NULL
regulator	NULL
of	NULL
IL-2	NULL
induction	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

12	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
a	NULL
crucial	NULL
component	NULL
of	NULL
the	NULL
multifactor	NULL
IL-2	NULL
promoter	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
require	NULL
an	NULL
association	NULL
between	NULL
all	NULL
of	NULL
its	NULL
components	NULL
for	NULL
full	NULL
promoter	NULL
activity	NULL
(	NULL
8	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
requirements	NULL
of	NULL
AP-1	NULL
in	NULL
IL-2	NULL
induction	NULL
,	NULL
a	NULL
mixture	NULL
of	NULL
polyclonal	NULL
Abs	NULL
to	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
was	NULL
scrape	NULL
loaded	NULL
into	NULL
primary	NULL
human	NULL
PB-T	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
activated	NULL
for	NULL
6	NULL
h	NULL
,	NULL
with	NULL
FIGURE	NULL
5	NULL
.	NULL

CD28	NULL
costimulation	NULL
of	NULL
IL-2	NULL
production	NULL
occurs	NULL
in	NULL
CD4*	NULL
and	NULL
CD4SRO	NULL
*	NULL
subsets	NULL
preferentially	NULL
.	NULL

A	NULL
,	NULL
Purified	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
were	NULL
collected	NULL
from	NULL
a	NULL
total	NULL
of	NULL
12	NULL
donors	NULL
.	NULL

CD45RO	NULL
and	NULL
CD4	NULL
cell	NULL
surface	NULL
molecules	NULL
were	NULL
stained	NULL
,	NULL
and	NULL
intracellular	NULL
IL-2	NULL
was	NULL
calculated	NULL
for	NULL
each	NULL
subpopulation	NULL
,	NULL
according	NULL
to	NULL
the	NULL
following	NULL
formula	NULL
:	NULL
percentage	NULL
of	NULL
IL-2	NULL
positive	NULL
=	NULL
(	NULL
(	NULL
IL-2	NULL
%	NULL
*	NULL
for	NULL
given	NULL
subset	NULL
)	NULL
/	NULL
(	NULL
total	NULL
percentage	NULL
of	NULL
a	NULL
given	NULL
subset	NULL
in	NULL
the	NULL
whole	NULL
population	NULL
)	NULL
)	NULL
X	NULL
100	NULL
.	NULL

B	NULL
,	NULL
In	NULL
donor	NULL
A	NULL
,	NULL
CDA45RO	NULL
and	NULL
CD4	NULL
cell	NULL
surface	NULL
molecules	NULL
were	NULL
stained	NULL
along	NULL
with	NULL
intracellular	NULL
IL-2	NULL
after	NULL
costimulation	NULL
by	NULL
Abs	NULL
to	NULL
CD28/CD3	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4	NULL
M	NULL
monensin	NULL
.	NULL

In	NULL
donor	NULL
B	NULL
,	NULL
CD45RA	NULL
and	NULL
CD8	NULL
were	NULL
stained	NULL
in	NULL
conjunction	NULL
with	NULL
intracellular	NULL
IL-2	NULL
after	NULL
costimulation	NULL
by	NULL
Abs	NULL
to	NULL
CD28/CD3	NULL
.	NULL

Left	NULL
panels	NULL
for	NULL
donor	NULL
A	NULL
and	NULL
donor	NULL
B	NULL
are	NULL
isotype-matched	NULL
control	NULL
stains	NULL
for	NULL
intracellular	NULL
IL-2	NULL
analyses	NULL
,	NULL
and	NULL
a	NULL
minimum	NULL
of	NULL
2	NULL
X	NULL
10+	NULL
events	NULL
was	NULL
measured	NULL
for	NULL
each	NULL
test	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
No	NULL
Treatment	NULL
Cyclosporin	NULL
A	NULL
(	NULL
0.5	NULL
ug/m	NULL
!	NULL
)	NULL

6.8	NULL
}	NULL
20.1	NULL
1.417.0	NULL
42.9|48.7	NULL
s	NULL
|___|	NULL
SH	NULL
Cell	NULL
Surface	NULL
CD45	NULL
RO	NULL
FIGURE	NULL
6	NULL
.	NULL

Inhibition	NULL
of	NULL
CD3/CD28	NULL
costimulation	NULL
of	NULL
IL-2	NULL
production	NULL
by	NULL
the	NULL
pharmacologic	NULL
agent	NULL
CsA	NULL
.	NULL

The	NULL
decrease	NULL
in	NULL
intracellular	NULL
accumulation	NULL
of	NULL
IL-2	NULL
was	NULL
measured	NULL
when	NULL
PB-T	NULL
cells	NULL
were	NULL
costimulated	NULL
with	NULL
CD3/	NULL
CD28	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
of	NULL
CsA	NULL
(	NULL
0.5	NULL
ug/ml	NULL
)	NULL
.	NULL

CD4SRO*	NULL
gates	NULL
were	NULL
set	NULL
from	NULL
the	NULL
analysis	NULL
of	NULL
fluorochrome/isotype-matched	NULL
control	NULL
mAbs	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
minimum	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
events	NULL
was	NULL
analyzed	NULL
per	NULL
test	NULL
.	NULL

high	NULL
concentrations	NULL
of	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
ionomycin	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
harvested	NULL
,	NULL
fixed	NULL
overnight	NULL
,	NULL
and	NULL
stained	NULL
for	NULL
intracellular	NULL
IL-2	NULL
.	NULL

As	NULL
Figure	NULL
7	NULL
demonstrates	NULL
,	NULL
samples	NULL
that	NULL
were	NULL
either	NULL
not	NULL
scraped	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
,	NULL
scrape	NULL
loaded	NULL
with	NULL
RAM	NULL
control	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
,	NULL
or	NULL
scrape	NULL
loaded	NULL
with	NULL
polyclonal	NULL
anti-c-Fos	NULL
and	NULL
anti-c-Jun	NULL
Abs	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
all	NULL
demonstrated	NULL
significant	NULL
production	NULL
of	NULL
IL-2	NULL
.	NULL

However	NULL
,	NULL
the	NULL
sample	NULL
that	NULL
had	NULL
been	NULL
scrape	NULL
loaded	NULL
with	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
Abs	NULL
showed	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
IL-2	NULL
production	NULL
(	NULL
a	NULL
41.6	NULL
%	NULL
decrease	NULL
in	NULL
IL-2	NULL
*	NULL
cells	NULL
from	NULL
25	NULL
%	NULL
to	NULL
14.6	NULL
%	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
dose	NULL
dependent	NULL
and	NULL
correlated	NULL
with	NULL
a	NULL
decrease	NULL
in	NULL
IL-2	NULL
message	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
Northern	NULL
blotting	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
IL-2	NULL
seen	NULL
when	NULL
the	NULL
anti-c-Fos	NULL
and	NULL
anti-c-Jun	NULL
Abs	NULL
were	NULL
used	NULL
alone	NULL
was	NULL
comparable	NULL
with	NULL
the	NULL
inhibition	NULL
seen	NULL
when	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
Abs	NULL
was	NULL
used	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Under	NULL
a	NULL
more	NULL
relevant	NULL
T	NULL
cell	NULL
activation	NULL
setting	NULL
,	NULL
IL-2	NULL
production	NULL
was	NULL
induced	NULL
by	NULL
coimmobilizing	NULL
mAbs	NULL
specific	NULL
for	NULL
the	NULL
CD3	NULL
complex	NULL
and	NULL
CD28	NULL
.	NULL

In	NULL
Figure	NULL
8	NULL
(	NULL
summarized	NULL
in	NULL
Table	NULL
III	NULL
)	NULL
,	NULL
RAM	NULL
scrape-loaded	NULL
PB-T	NULL
cells	NULL
(	NULL
middle	NULL
panels	NULL
,	NULL
top	NULL
and	NULL
bottom	NULL
)	NULL
were	NULL
compared	NULL
with	NULL
scrape	NULL
loading	NULL
of	NULL
a	NULL
mixture	NULL
of	NULL
polyclonal	NULL
Abs	NULL
to	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
(	NULL
right	NULL
panels	NULL
,	NULL
top	NULL
and	NULL
bottom	NULL
)	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
CD3/CD28	NULL
costimulation	NULL
.	NULL

Three-color	NULL
flow	NULL
cytometry	NULL
was	NULL
used	NULL
to	NULL
analyze	NULL
intracellular	NULL
IL-2	NULL
accumulation	NULL
within	NULL
CD45RO	NULL
*~	NULL
and	NULL
CD4*'~	NULL
subpopulations	NULL
of	NULL
PB-T	NULL
lymphocytes	NULL
,	NULL
as	NULL
described	NULL
for	NULL
Figure	NULL
4C	NULL
.	NULL

The	NULL
left	NULL
panel	NULL
of	NULL
Figure	NULL
8	NULL
(	NULL
``	NULL
control	NULL
stain	NULL
,	NULL
``	NULL
fop	NULL
and	NULL
bottom	NULL
panels	NULL
)	NULL
represents	NULL
background	NULL
fluorescence	NULL
(	NULL
irrelevant	NULL
rat	NULL
IgG2a	NULL
PE	NULL
)	NULL
of	NULL
the	NULL
RAM-scraped	NULL
CD4SRO	NULL
'	NULL
--	NULL
and	NULL
CD4	NULL
*'~-activated	NULL
cell	NULL
populations	NULL
,	NULL
serving	NULL
as	NULL
a	NULL
control	NULL
for	NULL
the	NULL
rat	NULL
Table	NULL
II	NULL
.	NULL

-	NULL
Inhibition	NULL
of	NULL
CD28-induced	NULL
intracellular	NULL
IL-2	NULL
accumulation	NULL
by	NULL
CsA	NULL
%	NULL
of	NULL
Cells	NULL
Positive	NULL
for	NULL
IL-2	NULL
in	NULL
T	NULL
Cell	NULL
Subsets	NULL
``	NULL
CDA4SRO~	NULL
Treatment	NULL
%	NULL
positive	NULL
%	NULL
dec	NULL
``	NULL
%	NULL
positive	NULL
%	NULL
dec	NULL
None	NULL
40.0	NULL
13.6	NULL
CsA	NULL
12.6	NULL
68.5	NULL
3.2	NULL
76.5	NULL
``	NULL
The	NULL
percentage	NULL
of	NULL
cells	NULL
positive	NULL
for	NULL
IL-2	NULL
in	NULL
various	NULL
T	NULL
cells	NULL
subsets	NULL
was	NULL
calculated	NULL
according	NULL
to	NULL
the	NULL
following	NULL
formula	NULL
:	NULL
%	NULL
positive	NULL
=	NULL
[	NULL
(	NULL
IL-2	NULL
%	NULL
*	NULL
for	NULL
given	NULL
subset	NULL
)	NULL
/	NULL
(	NULL
total	NULL
%	NULL
*	NULL
of	NULL
given	NULL
subset	NULL
in	NULL
the	NULL
whole	NULL
population	NULL
)	NULL
]	NULL
X	NULL
100	NULL
.	NULL

*	NULL
%	NULL
dec	NULL
represents	NULL
the	NULL
percentage	NULL
decrease	NULL
in	NULL
IL-2-positive	NULL
cells	NULL
compared	NULL
with	NULL
the	NULL
CsA-untreated	NULL
T	NULL
cells	NULL
.	NULL

%	NULL
dec	NULL
=	NULL
[	NULL
1	NULL
-	NULL
(	NULL
%	NULL
positive	NULL
cells	NULL
,	NULL
,4/	NULL
%	NULL
positive	NULL
cellsxy	NULL
xX	NULL
100	NULL
.	NULL

655	NULL
Non	NULL
Scrape	NULL
Ram	NULL
Scrape-	NULL
Anti-cFos	NULL
and	NULL
-cJun	NULL
Loaded	NULL
Loaded	NULL
Scrape-Loaded	NULL
24.17	NULL
%	NULL
25.0	NULL
%	NULL
14.6	NULL
%	NULL
Cell	NULL
Number	NULL
Intracellular	NULL
IL-2	NULL
FIGURE	NULL
7	NULL
.	NULL

-	NULL
Scrape	NULL
loading	NULL
of	NULL
Abs	NULL
specific	NULL
for	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
inhibits	NULL
intracellular	NULL
IL-2	NULL
production	NULL
induced	NULL
by	NULL
PMA	NULL
and	NULL
ionomycin	NULL
.	NULL

Intracellular	NULL
staining	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

At	NULL
least	NULL
2	NULL
X	NULL
10°	NULL
events	NULL
were	NULL
measured	NULL
for	NULL
each	NULL
condition	NULL
,	NULL
and	NULL
PMA	NULL
was	NULL
used	NULL
at	NULL
50	NULL
ng/ml	NULL
,	NULL
and	NULL
ionomycin	NULL
at	NULL
2	NULL
pg/ml	NULL
.	NULL

Gray	NULL
histograms	NULL
are	NULL
nonspecific	NULL
isotype	NULL
control	NULL
rat	NULL
IgG1	NULL
PE	NULL
.	NULL

Black	NULL
histograms	NULL
are	NULL
rat	NULL
anti-human	NULL
IL-2	NULL
IgG1	NULL
PE	NULL
.	NULL

These	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
.	NULL

anti-human	NULL
IL-2	NULL
IgG2a	NULL
PE	NULL
.	NULL

As	NULL
summarized	NULL
in	NULL
Table	NULL
III	NULL
,	NULL
inhibition	NULL
of	NULL
CD28/CD3	NULL
costimulation	NULL
of	NULL
IL-2	NULL
production	NULL
occurred	NULL
in	NULL
all	NULL
of	NULL
the	NULL
subsets	NULL
measured	NULL
.	NULL

CD4SRO	NULL
*	NULL
subsets	NULL
showed	NULL
a	NULL
decrease	NULL
of	NULL
17.3	NULL
%	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
IL-2-positive	NULL
cells	NULL
when	NULL
scrape	NULL
loaded	NULL
with	NULL
anti-AP-1	NULL
Abs	NULL
.	NULL

However	NULL
,	NULL
the	NULL
CD45RO~	NULL
subset	NULL
(	NULL
by	NULL
default	NULL
the	NULL
CD45RA	NULL
*	NULL
subset	NULL
)	NULL
demonstrated	NULL
a	NULL
decrease	NULL
of	NULL
42.1	NULL
%	NULL
.	NULL

The	NULL
decrease	NULL
in	NULL
IL-2-positive	NULL
cells	NULL
from	NULL
CD4	NULL
*	NULL
and	NULL
CD4~	NULL
subsets	NULL
was	NULL
26.3	NULL
and	NULL
49.3	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
transcription	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
and	NULL
that	NULL
their	NULL
requirement	NULL
for	NULL
IL-2	NULL
production	NULL
is	NULL
more	NULL
stringent	NULL
in	NULL
the	NULL
naive	NULL
~	NULL
)	NULL
subset	NULL
.	NULL

Discussion	NULL
In	NULL
T	NULL
lymphocytes	NULL
,	NULL
a	NULL
combination	NULL
of	NULL
signals	NULL
emanating	NULL
from	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
and	NULL
costimulatory	NULL
molecules	NULL
culminates	NULL
in	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

At	NULL
this	NULL
point	NULL
of	NULL
signal	NULL
convergence	NULL
,	NULL
a	NULL
number	NULL
of	NULL
transcription	NULL
factors	NULL
coordinately	NULL
regulates	NULL
maximal	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

Since	NULL
the	NULL
first	NULL
demonstration	NULL
of	NULL
the	NULL
immediate	NULL
upstream	NULL
DNA	NULL
sequence	NULL
as	NULL
a	NULL
key	NULL
element	NULL
in	NULL
inducible	NULL
IL-2	NULL
gene	NULL
expression	NULL
(	NULL
20	NULL
)	NULL
,	NULL
a	NULL
large	NULL
body	NULL
of	NULL
work	NULL
has	NULL
identified	NULL
many	NULL
transcriptional	NULL
complexes	NULL
suggested	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
promoter	NULL
activity	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

12	NULL
and	NULL
21	NULL
)	NULL
.	NULL

A	NULL
variety	NULL
of	NULL
methods	NULL
has	NULL
been	NULL
utilized	NULL
to	NULL
demonstrate	NULL
the	NULL
involvement	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
control	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
,	NULL
including	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
DNA	NULL
footprinting	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
(	NULL
and	NULL
supershift	NULL
)	NULL
assays	NULL
of	NULL
nuclear	NULL
protein	NULL
extracts	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
,	NULL
and	NULL
transcriptional	NULL
reporter	NULL
assays	NULL
involving	NULL
extrachromosomal	NULL
promoters	NULL
transfected	NULL
into	NULL
T	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Pharmacologic	NULL
agents	NULL
such	NULL
as	NULL
CsA	NULL
or	NULL
cAMP	NULL
provide	NULL
indirect	NULL
evidence	NULL
of	NULL
transcription	NULL
factor	NULL
involvement	NULL
in	NULL
IL-2	NULL
gene	NULL
induction	NULL
,	NULL
by	NULL
inhibiting	NULL
signal-transduction	NULL
pathways	NULL
before	NULL
nuclear	NULL
effects	NULL
on	NULL
transcription	NULL
factor	NULL
activity	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
techniques	NULL
have	NULL
been	NULL
indispensable	NULL
in	NULL
the	NULL
enumeration	NULL
of	NULL
factors	NULL
interacting	NULL
with	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
their	NULL
ability	NULL
to	NULL
promote	NULL
transcription	NULL
,	NULL
interpretation	NULL
of	NULL
their	NULL
physiologic	NULL
activity	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
of	NULL
primary	NULL
T	NULL
lymphocytes	NULL
,	NULL
in	NULL
which	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
within	NULL
its	NULL
correct	NULL
chromosomal	NULL
context	NULL
,	NULL
is	NULL
complex	NULL
.	NULL

Correct	NULL
chromosomal	NULL
context	NULL
is	NULL
an	NULL
important	NULL
aspect	NULL
,	NULL
as	NULL
it	NULL
is	NULL
becoming	NULL
increasingly	NULL
apparent	NULL
that	NULL
there	NULL
are	NULL
positional	NULL
DNA	NULL
effects	NULL
regulating	NULL
promoter	NULL
activity	NULL
.	NULL

For	NULL
example	NULL
,	NULL
genetic	NULL
sequences	NULL
can	NULL
serve	NULL
as	NULL
boundaries	NULL
between	NULL
tran-scriptionally	NULL
active	NULL
and	NULL
inactive	NULL
DNA	NULL
.	NULL

These	NULL
sequences	NULL
are	NULL
hypothesized	NULL
to	NULL
delineate	NULL
domains	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
avoiding	NULL
promiscuous	NULL
interactions	NULL
between	NULL
promoters	NULL
and	NULL
enhancers	NULL
of	NULL
spatially	NULL
distinct	NULL
genes	NULL
(	NULL
24	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
upstream	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
region	NULL
are	NULL
poorly	NULL
studied	NULL
sequences	NULL
thought	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
providing	NULL
cell	NULL
type	NULL
specificity	NULL
with	NULL
respect	NULL
to	NULL
IL-2	NULL
production	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
656	NULL
CD28/CD3	NULL
COSTIMULATION	NULL
OF	NULL
PRIMARY	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
REQUIRES	NULL
AP-1	NULL
Control	NULL
Stain	NULL
Ram	NULL
Scraped	NULL
Loaded	NULL
Anti-cFos/-cJun	NULL
Scrape	NULL
Loaded	NULL
9.9	NULL
118.0	NULL
54.3117.8	NULL
15.4	NULL
!	NULL

256	NULL
42.6116.5	NULL
E	NULL
0.2	NULL
)	NULL
0.7	NULL
a	NULL
65.7	NULL
]	NULL
33.4	NULL
3	NULL
os	NULL
©	NULL
3	NULL
al	NULL
3	NULL
€	NULL
]	NULL
F	NULL
[	NULL
easily	NULL
[	NULL
~	NULL
6	NULL
L	NULL
``	NULL
S	NULL
O	NULL
E	NULL
al-	NULL
(	NULL
Cell	NULL
Surface	NULL
CD45	NULL
RO	NULL
Cell	NULL
Surface	NULL
CD4	NULL
Cell	NULL
Surface	NULL
CD4	NULL
*	NULL
ntrol	NULL
FIGURE	NULL
8	NULL
.	NULL

CD28-induced	NULL
costimulation	NULL
of	NULL
IL-2	NULL
production	NULL
inhibited	NULL
by	NULL
scrape	NULL
loading	NULL
a	NULL
mixture	NULL
of	NULL
polyclonal	NULL
Abs	NULL
specific	NULL
for	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
transcription	NULL
complexes	NULL
.	NULL

PB-T	NULL
cells	NULL
were	NULL
either	NULL
scrape	NULL
loaded	NULL
with	NULL
RAM	NULL
(	NULL
RAM	NULL
Scrape	NULL
Loaded	NULL
)	NULL
,	NULL
or	NULL
a	NULL
mixture	NULL
of	NULL
rabbit	NULL
Abs	NULL
specific	NULL
for	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
(	NULL
Anti-c-Fos/c-Jun	NULL
Scrape	NULL
Loaded	NULL
)	NULL
was	NULL
activated	NULL
by	NULL
costimulation	NULL
with	NULL
CD3	NULL
and	NULL
CD28	NULL
mAbs	NULL
.	NULL

Three-color	NULL
FACS	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Control	NULL
staining	NULL
(	NULL
left	NULL
panels	NULL
,	NULL
top	NULL
and	NULL
bottom	NULL
)	NULL
represents	NULL
nonspecific	NULL
rat	NULL
IgG2a	NULL
PE	NULL
Ab	NULL
background	NULL
staining	NULL
of	NULL
CD4SRO	NULL
*~	NULL
and	NULL
CD4	NULL
*'~	NULL
subpopulations	NULL
of	NULL
costimulated	NULL
T	NULL
cells	NULL
scrape	NULL
loaded	NULL
with	NULL
RAM	NULL
.	NULL

A	NULL
minimum	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
events	NULL
was	NULL
analyzed	NULL
per	NULL
test	NULL
.	NULL

(	NULL
12	NULL
)	NULL
.	NULL

Transiently	NULL
transfected	NULL
promoter/reporter	NULL
constructs	NULL
containing	NULL
the	NULL
bare	NULL
minimal	NULL
upstream	NULL
elements	NULL
lack	NULL
these	NULL
insulator	NULL
or	NULL
boundary	NULL
sequences	NULL
,	NULL
and	NULL
far	NULL
upstream	NULL
regulatory	NULL
sequences	NULL
,	NULL
thus	NULL
not	NULL
reflecting	NULL
promoter	NULL
activity	NULL
within	NULL
the	NULL
original	NULL
chromosomal	NULL
context	NULL
.	NULL

To	NULL
date	NULL
,	NULL
the	NULL
only	NULL
methods	NULL
available	NULL
for	NULL
determination	NULL
of	NULL
transcription	NULL
factor	NULL
activity	NULL
in	NULL
the	NULL
promotion	NULL
of	NULL
gene	NULL
expression	NULL
under	NULL
physiologic	NULL
conditions	NULL
in	NULL
which	NULL
promoters	NULL
are	NULL
maintained	NULL
within	NULL
their	NULL
natural	NULL
context	NULL
have	NULL
been	NULL
the	NULL
use	NULL
of	NULL
genetically	NULL
altered	NULL
cell	NULL
lines	NULL
or	NULL
mouse	NULL
models	NULL
.	NULL

These	NULL
alterations	NULL
have	NULL
come	NULL
in	NULL
the	NULL
form	NULL
of	NULL
gene	NULL
ablation	NULL
studies	NULL
such	NULL
as	NULL
transcription	NULL
factor	NULL
knockout	NULL
(	NULL
KO	NULL
)	NULL
experiments	NULL
or	NULL
mutational	NULL
analysis	NULL
(	NULL
from	NULL
either	NULL
chemically	NULL
induced	NULL
mutations	NULL
or	NULL
homologous	NULL
recombination	NULL
)	NULL
of	NULL
transcription	NULL
factor	NULL
DNA-binding	NULL
sequences	NULL
that	NULL
prevent	NULL
DNA/factor	NULL
interactions	NULL
.	NULL

Although	NULL
the	NULL
transcription	NULL
factors	NULL
c-Fos	NULL
(	NULL
14	NULL
)	NULL
,	NULL
c-Jun	NULL
(	NULL
15	NULL
)	NULL
,	NULL
NF-AT1	NULL
(	NULL
25	NULL
)	NULL
,	NULL
and	NULL
NF-KB	NULL
proteins	NULL
(	NULL
RelA	NULL
,	NULL
c-Rel	NULL
,	NULL
RelB	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
I	NULL
«	NULL
kBa	NULL
)	NULL
(	NULL
26-30	NULL
)	NULL
have	NULL
been	NULL
studied	NULL
in	NULL
mouse	NULL
KO	NULL
models	NULL
,	NULL
only	NULL
those	NULL
of	NULL
the	NULL
NF-KB	NULL
family	NULL
have	NULL
demonstrated	NULL
involvement	NULL
in	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
after	NULL
direct	NULL
costimulation	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
c-Rel	NULL
'~	NULL
mice	NULL
showed	NULL
drastic	NULL
decreases	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
after	NULL
costimulation	NULL
with	NULL
CD28	NULL
and	NULL
CD3	NULL
Abs	NULL
,	NULL
even	NULL
though	NULL
mutating	NULL
the	NULL
NF-KB	NULL
site	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
has	NULL
only	NULL
slight	NULL
effects	NULL
(	NULL
13	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
KO	NULL
experiments	NULL
demonstrate	NULL
that	NULL
these	NULL
transcription	NULL
factors	NULL
are	NULL
either	NULL
not	NULL
involved	NULL
in	NULL
IL-2	NULL
transcription	NULL
,	NULL
or	NULL
more	NULL
likely	NULL
,	NULL
that	NULL
there	NULL
is	NULL
functional	NULL
redundancy	NULL
within	NULL
the	NULL
family	NULL
members	NULL
of	NULL
these	NULL
genes	NULL
,	NULL
such	NULL
that	NULL
the	NULL
adult	NULL
animal	NULL
has	NULL
Table	NULL
IM	NULL
.	NULL

-	NULL
Scrape	NULL
loading	NULL
of	NULL
a	NULL
combination	NULL
of	NULL
polyclonal	NULL
antibodies	NULL
specific	NULL
for	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
inhibit	NULL
production	NULL
of	NULL
IL-2	NULL
induced	NULL
by	NULL
costimulation	NULL
with	NULL
CD3/CD28	NULL
mAbs	NULL
%	NULL
of	NULL
Cells	NULL
Positive	NULL
for	NULL
IL-2	NULL
in	NULL
T	NULL
Cell	NULL
Subpopulations*	NULL
CD4SRO*	NULL
CD4SRO~	NULL
CD4*	NULL
CD4~	NULL
Scrape	NULL
%	NULL
o	NULL
%	NULL
o	NULL
%	NULL
o	NULL
%	NULL
o	NULL
Treatment	NULL
positive	NULL
%	NULL
dec	NULL
``	NULL
positive	NULL
%	NULL
dec	NULL
positive	NULL
%	NULL
dec	NULL
positive	NULL
%	NULL
dec	NULL
RAM	NULL
60.8	NULL
26.6	NULL
55.9	NULL
13.8	NULL
AP-1	NULL
50.3	NULL
17.3	NULL
15.4	NULL
42.1	NULL
41.2	NULL
26.3	NULL
7.0	NULL
49.3	NULL
``	NULL
The	NULL
percentage	NULL
of	NULL
cells	NULL
positive	NULL
for	NULL
IL-2	NULL
in	NULL
various	NULL
T	NULL
cell	NULL
subsets	NULL
was	NULL
calculated	NULL
according	NULL
to	NULL
the	NULL
following	NULL
formula	NULL
:	NULL
%	NULL
positive	NULL
=	NULL
[	NULL
IL-2	NULL
%	NULL
positive	NULL
for	NULL
given	NULL
subset	NULL
)	NULL
/	NULL
(	NULL
total	NULL
%	NULL
*	NULL
of	NULL
given	NULL
subset	NULL
in	NULL
the	NULL
whole	NULL
population	NULL
)	NULL
]	NULL
X	NULL
100	NULL
.	NULL

*	NULL
%	NULL
dec	NULL
represents	NULL
the	NULL
percentage	NULL
decrease	NULL
in	NULL
IL-2-positive	NULL
cells	NULL
compared	NULL
with	NULL
the	NULL
RAM	NULL
control	NULL
scraped	NULL
T	NULL
cells	NULL
.	NULL

%	NULL
dec	NULL
=	NULL
[	NULL
1	NULL
~	NULL
(	NULL
%	NULL
``	NULL
``	NULL
CEUsS	NULL
,	NULL
,	NULL
,	NULL
,	NULL
]	NULL
]	NULL
X	NULL
100	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
compensated	NULL
for	NULL
their	NULL
absence	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-2	NULL
production	NULL
.	NULL

T	NULL
cells	NULL
generated	NULL
from	NULL
mice	NULL
deficient	NULL
in	NULL
NF-AT1	NULL
have	NULL
demonstrated	NULL
Ag	NULL
hyperresponsiveness	NULL
,	NULL
so	NULL
it	NULL
has	NULL
been	NULL
postulated	NULL
that	NULL
NF-AT1l	NULL
is	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
certain	NULL
molecules	NULL
involved	NULL
in	NULL
the	NULL
down-regulation	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
,	NULL
such	NULL
as	NULL
the	NULL
CTLA-4	NULL
molecule	NULL
.	NULL

This	NULL
communication	NULL
describes	NULL
a	NULL
method	NULL
independent	NULL
of	NULL
genetic	NULL
manipulation	NULL
for	NULL
analyzing	NULL
the	NULL
involvement	NULL
of	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
.	NULL

This	NULL
method	NULL
involves	NULL
scrape	NULL
loading	NULL
anti-transcription	NULL
factor	NULL
Abs	NULL
into	NULL
freshly	NULL
isolated	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
whereby	NULL
cellular	NULL
functionality	NULL
as	NULL
measured	NULL
by	NULL
the	NULL
costimulation	NULL
of	NULL
proliferation	NULL
and	NULL
IL-2	NULL
production	NULL
is	NULL
maintained	NULL
.	NULL

This	NULL
has	NULL
allowed	NULL
the	NULL
intracellular	NULL
incorporation	NULL
of	NULL
Abs	NULL
specific	NULL
for	NULL
AP-1	NULL
,	NULL
and	NULL
the	NULL
measurement	NULL
of	NULL
the	NULL
effect	NULL
these	NULL
Abs	NULL
have	NULL
on	NULL
IL-2	NULL
gene	NULL
expression	NULL
induced	NULL
under	NULL
different	NULL
activation	NULL
conditions	NULL
.	NULL

Since	NULL
its	NULL
first	NULL
introduction	NULL
(	NULL
31	NULL
)	NULL
,	NULL
scrape	NULL
loading	NULL
has	NULL
been	NULL
used	NULL
in	NULL
a	NULL
number	NULL
of	NULL
experimental	NULL
systems	NULL
for	NULL
the	NULL
incorporation	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
reagents	NULL
:	NULL
lucifer	NULL
yellow	NULL
for	NULL
measurements	NULL
of	NULL
gap	NULL
junction	NULL
activity	NULL
(	NULL
32	NULL
)	NULL
;	NULL
the	NULL
small	NULL
GTP-binding	NULL
protein	NULL
p21	NULL
``	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
;	NULL
DNA	NULL
for	NULL
transfection	NULL
(	NULL
35	NULL
)	NULL
;	NULL
fluorinated	NULL
inositols	NULL
(	NULL
36	NULL
)	NULL
;	NULL
mAbs	NULL
(	NULL
37	NULL
)	NULL
;	NULL
restriction	NULL
endonucleases	NULL
(	NULL
38	NULL
)	NULL
;	NULL
phalloidin	NULL
(	NULL
39	NULL
)	NULL
;	NULL
and	NULL
Clostridium	NULL
botulinum	NULL
toxin	NULL
C3	NULL
(	NULL
40	NULL
)	NULL
.	NULL

The	NULL
technique	NULL
of	NULL
scrape	NULL
loading	NULL
is	NULL
based	NULL
on	NULL
the	NULL
principle	NULL
that	NULL
when	NULL
firmly	NULL
adherent	NULL
cells	NULL
are	NULL
physically	NULL
scraped	NULL
off	NULL
their	NULL
substrate	NULL
,	NULL
their	NULL
lipid	NULL
membranes	NULL
are	NULL
transiently	NULL
perforated	NULL
or	NULL
torn	NULL
and	NULL
quickly	NULL
reseal	NULL
.	NULL

As	NULL
the	NULL
membranes	NULL
reseal	NULL
,	NULL
intracellular	NULL
incorporation	NULL
of	NULL
some	NULL
of	NULL
the	NULL
extracellular	NULL
milieu	NULL
occurs	NULL
.	NULL

Scrape	NULL
loading	NULL
has	NULL
some	NULL
unique	NULL
advantages	NULL
to	NULL
other	NULL
published	NULL
techniques	NULL
for	NULL
the	NULL
introduction	NULL
of	NULL
reagents	NULL
intracellularly	NULL
,	NULL
in	NULL
that	NULL
it	NULL
allows	NULL
for	NULL
the	NULL
incorporation	NULL
of	NULL
nonspecific	NULL
reagents	NULL
for	NULL
appropriate	NULL
controls	NULL
.	NULL

For	NULL
example	NULL
,	NULL
in	NULL
the	NULL
incorporation	NULL
of	NULL
mAbs	NULL
,	NULL
other	NULL
methods	NULL
of	NULL
transiently	NULL
perforating	NULL
the	NULL
cell	NULL
membrane	NULL
,	NULL
such	NULL
as	NULL
in	NULL
the	NULL
case	NULL
of	NULL
Strep-tolysin	NULL
O	NULL
and	NULL
that	NULL
of	NULL
the	NULL
reversible	NULL
detergent	NULL
saponin	NULL
,	NULL
nonspecific	NULL
Abs	NULL
would	NULL
be	NULL
washed	NULL
out	NULL
in	NULL
subsequent	NULL
steps	NULL
as	NULL
the	NULL
resealing	NULL
of	NULL
the	NULL
membrane	NULL
does	NULL
not	NULL
immediately	NULL
follow	NULL
initial	NULL
perforation	NULL
.	NULL

With	NULL
the	NULL
technique	NULL
of	NULL
scrape	NULL
loading	NULL
,	NULL
large	NULL
quantities	NULL
of	NULL
cells	NULL
can	NULL
be	NULL
loaded	NULL
with	NULL
excess	NULL
specific	NULL
and	NULL
nonspecific	NULL
material	NULL
.	NULL

As	NULL
the	NULL
resealing	NULL
of	NULL
the	NULL
membranes	NULL
in	NULL
this	NULL
instance	NULL
is	NULL
very	NULL
fast	NULL
,	NULL
nonspecific	NULL
Abs	NULL
that	NULL
are	NULL
not	NULL
retained	NULL
within	NULL
the	NULL
cells	NULL
by	NULL
interaction	NULL
with	NULL
specific	NULL
epitopes	NULL
are	NULL
theoretically	NULL
incorporated	NULL
in	NULL
much	NULL
the	NULL
same	NULL
amounts	NULL
as	NULL
Abs	NULL
that	NULL
are	NULL
retained	NULL
through	NULL
Ab/Ag	NULL
interactions	NULL
.	NULL

In	NULL
this	NULL
manner	NULL
,	NULL
the	NULL
correct	NULL
nonspecific	NULL
controls	NULL
are	NULL
present	NULL
for	NULL
cellular	NULL
testing	NULL
.	NULL

The	NULL
studies	NULL
presented	NULL
in	NULL
this	NULL
work	NULL
indicate	NULL
that	NULL
the	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
gene	NULL
products	NULL
are	NULL
in	NULL
fact	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
production	NULL
in	NULL
freshly	NULL
isolated	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Scrape	NULL
loading	NULL
specific	NULL
Abs	NULL
to	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
into	NULL
isolated	NULL
T	NULL
cells	NULL
substantially	NULL
inhibited	NULL
IL-2	NULL
production	NULL
in	NULL
naive	NULL
(	NULL
CD45RO~	NULL
)	NULL
,	NULL
memory	NULL
(	NULL
CD45RO	NULL
*	NULL
)	NULL
,	NULL
CD4	NULL
*	NULL
,	NULL
and	NULL
CD4~	NULL
T	NULL
cell	NULL
subsets	NULL
when	NULL
costimulated	NULL
with	NULL
CD28	NULL
and	NULL
CD3	NULL
Abs	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
work	NULL
substantiate	NULL
molecular	NULL
studies	NULL
,	NULL
such	NULL
as	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
DNA	NULL
foot-printing	NULL
,	NULL
gel	NULL
shift	NULL
and	NULL
supershift	NULL
experiments	NULL
,	NULL
and	NULL
promoter	NULL
activity	NULL
assays	NULL
originally	NULL
suggesting	NULL
the	NULL
importance	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
in	NULL
IL-2	NULL
production	NULL
.	NULL

Scrape	NULL
loading	NULL
of	NULL
a	NULL
mixture	NULL
of	NULL
polyclonal	NULL
Ab	NULL
raised	NULL
against	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
demonstrates	NULL
a	NULL
more	NULL
pronounced	NULL
effect	NULL
on	NULL
CD45RO	NULL
-	NULL
T	NULL
cells	NULL
and	NULL
suggests	NULL
the	NULL
AP-1	NULL
complex	NULL
is	NULL
more	NULL
stringently	NULL
required	NULL
in	NULL
CD28/CD3	NULL
costimulation	NULL
of	NULL
IL-2	NULL
production	NULL
in	NULL
naive	NULL
T	NULL
cell	NULL
subsets	NULL
.	NULL

This	NULL
may	NULL
be	NULL
a	NULL
reflection	NULL
of	NULL
the	NULL
robust	NULL
IL-2	NULL
production	NULL
from	NULL
*	NULL
T	NULL
cell	NULL
subsets	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
CD4SRA*	NULL
subsets	NULL
.	NULL

There	NULL
are	NULL
a	NULL
number	NULL
of	NULL
mechanisms	NULL
by	NULL
which	NULL
the	NULL
Abs	NULL
may	NULL
be	NULL
inhibiting	NULL
IL-2	NULL
production	NULL
.	NULL

For	NULL
example	NULL
,	NULL
they	NULL
may	NULL
be	NULL
sequestering	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
preventing	NULL
their	NULL
nuclear	NULL
translocation	NULL
.	NULL

Or	NULL
,	NULL
if	NULL
the	NULL
Ab	NULL
can	NULL
shuttle	NULL
into	NULL
the	NULL
nucleus	NULL
via	NULL
association	NULL
with	NULL
the	NULL
factor	NULL
,	NULL
then	NULL
inhibition	NULL
of	NULL
either	NULL
DNA	NULL
binding	NULL
or	NULL
the	NULL
formation	NULL
of	NULL
quaternary	NULL
structures	NULL
with	NULL
DNA	NULL
and	NULL
other	NULL
tran	NULL
657	NULL
scription	NULL
factors	NULL
may	NULL
be	NULL
the	NULL
mechanism	NULL
of	NULL
action	NULL
.	NULL

Based	NULL
on	NULL
in	NULL
vivo	NULL
footprinting	NULL
data	NULL
,	NULL
one	NULL
would	NULL
reason	NULL
that	NULL
if	NULL
maximal	NULL
inhibition	NULL
of	NULL
any	NULL
one	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
were	NULL
to	NULL
occur	NULL
,	NULL
then	NULL
almost	NULL
complete	NULL
inhibition	NULL
of	NULL
IL-2	NULL
production	NULL
would	NULL
result	NULL
as	NULL
the	NULL
quaternary	NULL
structure	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
could	NULL
not	NULL
be	NULL
established	NULL
(	NULL
8	NULL
)	NULL
.	NULL

This	NULL
seems	NULL
to	NULL
be	NULL
the	NULL
case	NULL
in	NULL
RelA	NULL
'~	NULL
mice	NULL
,	NULL
in	NULL
which	NULL
T	NULL
cell	NULL
IL-2	NULL
production	NULL
is	NULL
decreased	NULL
~50-fold	NULL
when	NULL
compared	NULL
with	NULL
normal	NULL
mice	NULL
.	NULL

In	NULL
the	NULL
scrape-loading	NULL
model	NULL
with	NULL
anti-cFos	NULL
and	NULL
anti-c-Jun	NULL
Abs	NULL
presented	NULL
in	NULL
this	NULL
work	NULL
,	NULL
incomplete	NULL
inhibition	NULL
of	NULL
IL-2	NULL
production	NULL
was	NULL
found	NULL
,	NULL
which	NULL
may	NULL
indicate	NULL
submaximal	NULL
inhibition	NULL
of	NULL
transcription	NULL
factor	NULL
activity	NULL
.	NULL

This	NULL
is	NULL
most	NULL
likely	NULL
a	NULL
reflection	NULL
of	NULL
a	NULL
decrease	NULL
in	NULL
nuclear	NULL
AP-1	NULL
factors	NULL
available	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
complex	NULL
structure	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

This	NULL
has	NULL
allowed	NULL
the	NULL
recognition	NULL
that	NULL
more	NULL
stringent	NULL
conditions	NULL
exist	NULL
for	NULL
AP-1	NULL
transcription	NULL
factor	NULL
involvement	NULL
in	NULL
€CD28/CD3	NULL
costimulation	NULL
of	NULL
naive	NULL
T	NULL
cell	NULL
subpopulations	NULL
,	NULL
which	NULL
would	NULL
have	NULL
been	NULL
overlooked	NULL
if	NULL
complete	NULL
inhibition	NULL
of	NULL
T	NULL
cell	NULL
IL-2	NULL
production	NULL
were	NULL
to	NULL
have	NULL
occurred	NULL
.	NULL

To	NULL
date	NULL
,	NULL
the	NULL
most	NULL
compelling	NULL
evidence	NULL
for	NULL
implicating	NULL
certain	NULL
effector	NULL
molecules	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
has	NULL
come	NULL
from	NULL
genetic	NULL
experiments	NULL
involving	NULL
ablations	NULL
or	NULL
mutations	NULL
of	NULL
effector	NULL
molecules	NULL
involved	NULL
in	NULL
signaling	NULL
cascades	NULL
or	NULL
IL-2	NULL
transcription	NULL
.	NULL

Gene	NULL
KO	NULL
experiments	NULL
involving	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
have	NULL
been	NULL
inconclusive	NULL
in	NULL
the	NULL
determination	NULL
of	NULL
their	NULL
role	NULL
in	NULL
IL-2	NULL
transcription	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

In	NULL
this	NULL
communication	NULL
,	NULL
we	NULL
provide	NULL
a	NULL
method	NULL
to	NULL
incorporate	NULL
macromolecules	NULL
such	NULL
as	NULL
Ig	NULL
into	NULL
freshly	NULL
purified	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
.	NULL

Combining	NULL
this	NULL
with	NULL
an	NULL
approach	NULL
for	NULL
measuring	NULL
intracellular	NULL
IL-2	NULL
production	NULL
,	NULL
rapid	NULL
measurements	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
specific	NULL
reagents	NULL
on	NULL
components	NULL
of	NULL
intracellular	NULL
signaling	NULL
cascades	NULL
can	NULL
be	NULL
made	NULL
.	NULL

We	NULL
have	NULL
used	NULL
Abs	NULL
specific	NULL
for	NULL
transcription	NULL
factors	NULL
that	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
possible	NULL
players	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
under	NULL
a	NULL
variety	NULL
of	NULL
in	NULL
vitro	NULL
experimental	NULL
conditions	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
this	NULL
is	NULL
the	NULL
first	NULL
evidence	NULL
that	NULL
these	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
within	NULL
single	NULL
cells	NULL
of	NULL
the	NULL
primary	NULL
human	NULL
T	NULL
lymphocyte	NULL
naive	NULL
and	NULL
memory	NULL
subpopulations	NULL
,	NULL
in	NULL
which	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
within	NULL
its	NULL
correct	NULL
chromosomal	NULL
context	NULL
.	NULL

These	NULL
techniques	NULL
should	NULL
prove	NULL
fruitful	NULL
for	NULL
the	NULL
study	NULL
of	NULL
signal-transduction	NULL
pathways	NULL
and	NULL
T	NULL
cell	NULL
functional	NULL
responses	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
J.	NULL
N.	NULL
Wygant	NULL
for	NULL
technical	NULL
assistance	NULL
and	NULL
K.	NULL
Ramirez	NULL
for	NULL
FACS	NULL
analysis	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Lenschow	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
T.	NULL
L.	NULL
Walunas	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
.	NULL

1996	NULL
.	NULL

€CD28/B7	NULL
system	NULL
of	NULL
T	NULL
cell	NULL
costimulation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:233	NULL
.	NULL

2	NULL
.	NULL

Viola	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
A.	NULL
Lanzavecchia	NULL
.	NULL

1996	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
determined	NULL
by	NULL
T	NULL
cell	NULL
receptor	NULL
number	NULL
and	NULL
tunable	NULL
thresholds	NULL
.	NULL

Science	NULL
273:104	NULL
.	NULL

3	NULL
.	NULL

Jenkins	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1987	NULL
.	NULL

Antigen	NULL
presentation	NULL
by	NULL
chemically	NULL
modified	NULL
splenocytes	NULL
induces	NULL
antigen-specific	NULL
T	NULL
cell	NULL
unresponsiveness	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165:302	NULL
.	NULL

4	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
T.	NULL
Lindstein	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
S.	NULL
L.	NULL
Kunkel	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
S.	NULL
G.	NULL
Emerson	NULL
,	NULL
J.	NULL
M.	NULL
Leiden	NULL
,	NULL
and	NULL
C.	NULL
H.	NULL
June	NULL
.	NULL

1989	NULL
.	NULL

CD28	NULL
activation	NULL
pathway	NULL
regulates	NULL
the	NULL
production	NULL
of	NULL
multiple	NULL
T	NULL
cell-derived	NULL
lymphokines/cytokines	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:1333	NULL
.	NULL

5	NULL
.	NULL

Lindstein	NULL
,	NULL
T.	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
G.	NULL
Stella	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1989	NULL
.	NULL

Regulation	NULL
of	NULL
lymphokine	NULL
messenger	NULL
RNA	NULL
stability	NULL
by	NULL
a	NULL
surface-mediated	NULL
T	NULL
cell	NULL
activation	NULL
pathway	NULL
.	NULL

Science	NULL
244:339	NULL
.	NULL

6	NULL
.	NULL

Fraser	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Irving	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1991	NULL
.	NULL

Regulation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
enhancer	NULL
activity	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
accessory	NULL
molecule	NULL
CD28	NULL
.	NULL

Science	NULL
251:313	NULL
.	NULL

7	NULL
.	NULL

Serfling	NULL
,	NULL
E.	NULL
,	NULL
R.	NULL
Barthelmas	NULL
,	NULL
I.	NULL
Pfeuller	NULL
,	NULL
B.	NULL
Schenk	NULL
,	NULL
S.	NULL
Zarius	NULL
,	NULL
R.	NULL
Swoboda	NULL
,	NULL
F.	NULL
Mercurio	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1989	NULL
.	NULL

Ubiquitous	NULL
and	NULL
lymphocyte	NULL
specific	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
mouse	NULL
interleukin-2	NULL
gene	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:465	NULL
.	NULL

8	NULL
.	NULL

Chen	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
E.	NULL
V.	NULL
Rothenberg	NULL
.	NULL

1994	NULL
.	NULL

Interleukin-2	NULL
transcription	NULL
factors	NULL
as	NULL
molecular	NULL
targets	NULL
of	NULL
cAMP	NULL
inhibition	NULL
:	NULL
delayed	NULL
inhibition	NULL
kinetics	NULL
and	NULL
combinatorial	NULL
transcription	NULL
roles	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:931	NULL
.	NULL

9	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
C.	NULL
Gorka	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

T-cell-specific	NULL
expression	NULL
of	NULL
interleukin	NULL
2	NULL
:	NULL
evidence	NULL
for	NULL
a	NULL
negative	NULL
regulatory	NULL
site	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:2954	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
658	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
V.	NULL
E.	NULL
Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
356:801	NULL
.	NULL

Hughes	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Pober	NULL
.	NULL

1996	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
in	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
:	NULL
convergence	NULL
of	NULL
costimulatory	NULL
signals	NULL
and	NULL
differences	NULL
from	NULL
transformed	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:5369	NULL
.	NULL

Rothenberg	NULL
,	NULL
E.	NULL
V.	NULL
,	NULL
and	NULL
S.	NULL
B	NULL
.	NULL

Ward	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
dynamic	NULL
assembly	NULL
of	NULL
diverse	NULL
transcription	NULL
factors	NULL
integrates	NULL
activation	NULL
and	NULL
cell-type	NULL
information	NULL
for	NULL
interleukin-2	NULL
gene	NULL
regulation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:9358	NULL
.	NULL

Shapiro	NULL
,	NULL
V.	NULL
S.	NULL
,	NULL
M.	NULL
N.	NULL
Mollenauer	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1996.	NULL
c-rel	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
may	NULL
be	NULL
mediated	NULL
through	NULL
activation	NULL
of	NULL
AP-1	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:1663	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
A.	NULL
Nalefski	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
R.	NULL
S.	NULL
Johnson	NULL
,	NULL
B.	NULL
M.	NULL
Spiegelman	NULL
,	NULL
V.	NULL
Papaioannou	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1994	NULL
.	NULL

Normal	NULL
peripheral	NULL
T	NULL
cell	NULL
function	NULL
in	NULL
cFos	NULL
deficient	NULL
mice	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1566	NULL
.	NULL

Chen	NULL
,	NULL
J.	NULL
,	NULL
V.	NULL
Stewart	NULL
,	NULL
G.	NULL
Spyrou	NULL
,	NULL
F.	NULL
Hilberg	NULL
,	NULL
E.	NULL
F.	NULL
Wagner	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Alt	NULL
.	NULL

1994	NULL
.	NULL

Generation	NULL
of	NULL
normal	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
by	NULL
c-jun	NULL
deficient	NULL
embryonic	NULL
stem	NULL
cells	NULL
.	NULL

Immunity	NULL
1:65	NULL
.	NULL

Bednarezyk	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
J.	NULL
N.	NULL
Wygant	NULL
,	NULL
M.	NULL
C.	NULL
Szabo	NULL
,	NULL
L.	NULL
Molinari-Storey	NULL
,	NULL
M.	NULL
Renz	NULL
,	NULL
S.	NULL
Fong	NULL
,	NULL
and	NULL
B.	NULL
W.	NULL
McIntyre	NULL
.	NULL

1993	NULL
.	NULL

Homotypic	NULL
leukocyte	NULL
aggregation	NULL
triggered	NULL
by	NULL
a	NULL
monoclonal	NULL
antibody	NULL
specific	NULL
for	NULL
a	NULL
novel	NULL
epitope	NULL
expressed	NULL
by	NULL
the	NULL
integrin	NULL
B	NULL
,	NULL
subunit	NULL
:	NULL
conversion	NULL
of	NULL
nonresponsive	NULL
cells	NULL
by	NULL
transfecting	NULL
human	NULL
integrin	NULL
a	NULL
,	NULL
subunit	NULL
cDNA	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Biochem	NULL
.	NULL

51:465	NULL
.	NULL

Woodside	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
T.	NULL
K.	NULL
Teague	NULL
,	NULL
and	NULL
B.	NULL
W.	NULL
McIntyre	NULL
.	NULL

1996	NULL
.	NULL

Specific	NULL
inhibition	NULL
of	NULL
T	NULL
lymphocyte	NULL
coactivation	NULL
by	NULL
triggering	NULL
integrin	NULL
B	NULL
,	NULL
reveals	NULL
convergence	NULL
of	NULL
B	NULL
;	NULL
,	NULL
B	NULL
;	NULL
,	NULL
and	NULL
B	NULL
;	NULL
integrin	NULL
signaling	NULL
pathways	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:700	NULL
.	NULL

Udagawa	NULL
,	NULL
T.	NULL
,	NULL
D.	NULL
G.	NULL
Woodside	NULL
,	NULL
and	NULL
B.	NULL
W.	NULL
Mcintyre	NULL
.	NULL

1996.	NULL
a	NULL
,	NULL
,	NULL
(	NULL
CD494/CD29	NULL
)	NULL
integrin	NULL
costimulation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
enhances	NULL
transcription	NULL
factor	NULL
and	NULL
cytokine	NULL
induction	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
altered	NULL
sensitivity	NULL
to	NULL
anti-CD3	NULL
stimulation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:1965	NULL
.	NULL

Sander	NULL
,	NULL
B.	NULL
,	NULL
J.	NULL
Andersson	NULL
,	NULL
and	NULL
U.	NULL
Andersson	NULL
.	NULL

1991	NULL
.	NULL

Assessment	NULL
of	NULL
cytokines	NULL
by	NULL
immunofluorescence	NULL
and	NULL
the	NULL
paraformaldehyde-saponin	NULL
procedure	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

119:65	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Shibuya	NULL
,	NULL
T.	NULL
Obashi	NULL
,	NULL
K.	NULL
Yamanishi	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1986	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
interleukin-2	NULL
gene	NULL
:	NULL
functional	NULL
DNA	NULL
sequences	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
for	NULL
gene	NULL
expression	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
46:401	NULL
.	NULL

Serfling	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Avots	NULL
,	NULL
and	NULL
M.	NULL
Neumann	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
architecture	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
:	NULL
a	NULL
reflection	NULL
of	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1263:181	NULL
.	NULL

Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
C.	NULL
L.	NULL
Verweij	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
K.	NULL
M.	NULL
Higgins	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabiree	NULL
.	NULL

1989	NULL
.	NULL

Cyclosporin	NULL
A	NULL
specifically	NULL
inhibits	NULL
function	NULL
of	NULL
nuclear	NULL
proteins	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
246:1617	NULL
.	NULL

Tamir	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
N.	NULL
Isakov	NULL
.	NULL

1994	NULL
.	NULL

Cyclic	NULL
AMP	NULL
inhibits	NULL
phosphatidylinositol-cou-pled	NULL
and	NULL
-uncoupled	NULL
mitogenic	NULL
signals	NULL
in	NULL
T	NULL
lymphocytes	NULL
:	NULL
evidence	NULL
that	NULL
cAMP	NULL
alters	NULL
PKC-induced	NULL
transcription	NULL
regulation	NULL
of	NULL
members	NULL
of	NULL
the	NULL
jun	NULL
and	NULL
fos	NULL
family	NULL
of	NULL
genes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:3391	NULL
.	NULL

Felsenfeld	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
Boyes	NULL
,	NULL
J.	NULL
Chung	NULL
,	NULL
D.	NULL
Clark	NULL
,	NULL
and	NULL
V.	NULL
Studitsky	NULL
.	NULL

1996	NULL
.	NULL

Chromatin	NULL
structure	NULL
and	NULL
gene	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:9384	NULL
.	NULL

Xanthoudakis	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
P.	NULL
Viola	NULL
,	NULL
K.	NULL
T.	NULL
Shaw	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
J.	NULL
D.	NULL
Wallace	NULL
,	NULL
P.	NULL
T.	NULL
Bozza	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
enhanced	NULL
immune	NULL
response	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
.	NULL

Science	NULL
272:892	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

CD28/CD3	NULL
COSTIMULATION	NULL
OF	NULL
PRIMARY	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
REQUIRES	NULL
AP-1	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
C.	NULL
Sha	NULL
,	NULL
R.	NULL
T.	NULL
Bronson	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Embryonic	NULL
lethality	NULL
and	NULL
liver	NULL
degeneration	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
RelA	NULL
component	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
376:167	NULL
.	NULL

Kontgen	NULL
,	NULL
F.	NULL
,	NULL
R.	NULL
J.	NULL
Grumont	NULL
,	NULL
A.	NULL
Strasser	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
R.	NULL
Li	NULL
,	NULL
D.	NULL
Tarlington	NULL
,	NULL
and	NULL
S.	NULL
Gerondakis	NULL
.	NULL

1995	NULL
.	NULL

Mice	NULL
lacking	NULL
the	NULL
c-rel	NULL
proto-oncogene	NULL
exhibit	NULL
defects	NULL
in	NULL
lymphocyte	NULL
proliferation	NULL
,	NULL
humoral	NULL
immunity	NULL
,	NULL
and	NULL
interleukin	NULL
expression	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1965	NULL
.	NULL

Weih	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
Carrasco	NULL
,	NULL
S.	NULL
K.	NULL
Durham	NULL
,	NULL
D.	NULL
S.	NULL
Barton	NULL
,	NULL
C.	NULL
A.	NULL
Rizzo	NULL
,	NULL
R.	NULL
P.	NULL
Ryseck	NULL
,	NULL
S.	NULL
A.	NULL
Lira	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1995	NULL
.	NULL

Multi-organ	NULL
inflammation	NULL
and	NULL
hematopoietic	NULL
abnormalities	NULL
in	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
disruption	NULL
of	NULL
RelB	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
.	NULL

Cell	NULL
80:331	NULL
.	NULL

Sha	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
H.	NULL
C.	NULL
Liou	NULL
,	NULL
E.	NULL
I.	NULL
Tuomanen	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
leads	NULL
to	NULL
multifocal	NULL
defects	NULL
in	NULL
immune	NULL
responses	NULL
.	NULL

Cell	NULL
80:321	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
C.	NULL
Sha	NULL
,	NULL
R.	NULL
T.	NULL
Bronson	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Constitutive	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
enhanced	NULL
granulopoiesis	NULL
,	NULL
and	NULL
neonatal	NULL
lethality	NULL
in	NULL
I	NULL
«	NULL
Ba-defi-cient	NULL
mice	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:2736	NULL
.	NULL

McNeil	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
R.	NULL
F.	NULL
Murphy	NULL
,	NULL
F.	NULL
Lanni	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Taylor	NULL
.	NULL

1984	NULL
.	NULL

A	NULL
method	NULL
for	NULL
incorporating	NULL
macromolecules	NULL
into	NULL
adherent	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

98:1556	NULL
.	NULL

Kavanagh	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
G.	NULL
M.	NULL
Martin	NULL
,	NULL
M.	NULL
H.	NULL
el-Fouly	NULL
,	NULL
J.	NULL
E.	NULL
Trosko	NULL
,	NULL
C.	NULL
C.	NULL
Chang	NULL
,	NULL
and	NULL
P.	NULL
S.	NULL
Rabinovitch	NULL
.	NULL

1987	NULL
.	NULL

Flow	NULL
cytometry	NULL
and	NULL
scrape-loading/dye	NULL
transfer	NULL
as	NULL
a	NULL
rapid	NULL
quantitative	NULL
measure	NULL
of	NULL
intercellular	NULL
communication	NULL
in	NULL
vitro	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

47:6046	NULL
.	NULL

Morris	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
B	NULL
.	NULL

Price	NULL
,	NULL
A.	NULL
C.	NULL
Lloyd	NULL
,	NULL
A.	NULL
J.	NULL
Self	NULL
,	NULL
C.	NULL
J.	NULL
Marshall	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Hall	NULL
.	NULL

1989	NULL
.	NULL

Scrape-loading	NULL
of	NULL
Swiss	NULL
3T3	NULL
cells	NULL
with	NULL
ras	NULL
protein	NULL
rapidly	NULL
activates	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
phosphoinositide	NULL
hydrolysis	NULL
.	NULL

Oncogene	NULL
4:27	NULL
.	NULL

Price	NULL
,	NULL
B.	NULL
D.	NULL
,	NULL
J.	NULL
D.	NULL
Morris	NULL
,	NULL
C.	NULL
J.	NULL
Marshall	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Hall	NULL
.	NULL

1989	NULL
.	NULL

Scrape-loaded	NULL
p21	NULL
``	NULL
down-regulates	NULL
agonist-stimulated	NULL
inositol	NULL
phosphate	NULL
production	NULL
by	NULL
a	NULL
mechanism	NULL
involving	NULL
protein	NULL
kinase	NULL
C.	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

260:157	NULL
.	NULL

Fechheimer	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
F.	NULL
Boylan	NULL
,	NULL
S.	NULL
Parker	NULL
,	NULL
J.	NULL
E.	NULL
Sisken	NULL
,	NULL
G.	NULL
L.	NULL
Patel	NULL
,	NULL
and	NULL
S.	NULL
G.	NULL
Zimmer	NULL
.	NULL

1987	NULL
.	NULL

Transfection	NULL
of	NULL
mammalian	NULL
cells	NULL
with	NULL
plasmid	NULL
DNA	NULL
by	NULL
scrape	NULL
loading	NULL
and	NULL
sonication	NULL
loading	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:8463	NULL
.	NULL

Cosulich	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
J	NULL
.	NULL

Offer	NULL
,	NULL
G.	NULL
A.	NULL
Smith	NULL
,	NULL
R.	NULL
Hesketh	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Metcalfe	NULL
.	NULL

1993	NULL
.	NULL

Effects	NULL
of	NULL
fluorinated	NULL
inositols	NULL
on	NULL
the	NULL
proliferation	NULL
of	NULL
Swiss	NULL
3T3	NULL
fibroblasts	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

292:719	NULL
.	NULL

Roden	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Y.	NULL
Shachar-Hill	NULL
,	NULL
S.	NULL
C.	NULL
Cosulich	NULL
,	NULL
T.	NULL
R.	NULL
Hesketh	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Metcalfe	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
common	NULL
requirement	NULL
for	NULL
p21°-	NULL
``	NULL
``	NULL
function	NULL
in	NULL
the	NULL
mitogenic	NULL
signaling	NULL
pathways	NULL
of	NULL
Swiss	NULL
3T3	NULL
fibroblasts	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

4:957	NULL
.	NULL

Boes	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
G.	NULL
Obe	NULL
.	NULL

1993	NULL
.	NULL

Scrape-loading	NULL
:	NULL
a	NULL
simple	NULL
method	NULL
to	NULL
induce	NULL
chromosomal	NULL
aberrations	NULL
with	NULL
restriction	NULL
enzymes	NULL
in	NULL
CHO	NULL
cells	NULL
.	NULL

Mutat	NULL
.	NULL

Res	NULL
.	NULL

292:225	NULL
.	NULL

Bershadsky	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
U.	NULL
Gluck	NULL
,	NULL
O.	NULL
N.	NULL
Denisenko	NULL
,	NULL
T.	NULL
V.	NULL
Sklyarova	NULL
,	NULL
I.	NULL
Spector	NULL
,	NULL
and	NULL
A.	NULL
Ben-Ze'ev	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
state	NULL
of	NULL
actin	NULL
assembly	NULL
regulates	NULL
actin	NULL
and	NULL
vinculin	NULL
expression	NULL
by	NULL
a	NULL
feedback	NULL
loop	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

108:1183	NULL
.	NULL

Malcolm	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
C.	NULL
M.	NULL
Elliot	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Exton	NULL
.	NULL

1996	NULL
.	NULL

Evidence	NULL
for	NULL
rho-mediated	NULL
agonist	NULL
stimulation	NULL
of	NULL
phospholipase	NULL
D	NULL
in	NULL
rat1	NULL
fibroblasts	NULL
:	NULL
effects	NULL
of	NULL
Clostridium	NULL
botulinum	NULL
C3	NULL
exoenzyme	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:13135	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL

